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ABSTRACT 
 
Christy, Shannon M., Ph.D., Purdue University, August 2015. Relationships Between 
Masculinity Beliefs and Colorectal Cancer Screening in Male Veterans. Major Professor: 
Catherine E. Mosher. 
 
Colorectal cancer (CRC) is the third most common cancer diagnosed and the third 
most common cause of cancer deaths among men in the United States. Although CRC 
screening tests can reduce CRC incidence and mortality, men’s current rates of CRC 
screening fall below screening objectives. Results from qualitative studies have suggested 
masculinity to be a potential barrier to CRC screening as some men may find endoscopic 
screening procedures to breach masculinity norms. In prior studies, masculinity beliefs 
have been associated with preventive health behaviors as well as risk behaviors among 
men. However, to the author’s knowledge, no other quantitative studies have examined 
the relationship between masculinity and CRC screening adherence. The current study 
aimed to understand the relationship between three aspects of masculinity (i.e., self-
reliance, risk-taking, and heterosexual self-presentation), health beliefs, participant 
characteristics, and CRC screening adherence. It was hypothesized that the three aspects 
of masculinity would be inversely associated with CRC screening adherence. Data were 
collected from 350 men aged 51-75 at average risk for CRC who were accessing primary 
care services at a Veterans Affairs Medical Center. Of the 350 consenting individuals, 
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data from 327 participants were included in study analyses. Of those 327 participants, 
213 individuals were adherent to CRC screening guidelines and the remaining 114 were 
non-adherent. Correlational and logistic regression analyses were utilized to examine 
associations between aspects of masculinity and CRC screening adherence. Conditional 
process analyses were used to examine whether health belief variables (i.e., trust in 
physician and cancer fear) mediated the relationships between certain aspects of 
masculinity and CRC screening adherence. Next, participant characteristics (i.e., race, 
age, and length of relationship between the patient and his primary care provider) were 
examined as potential moderators of certain relationships in the models utilizing 
conditional process analyses. In addition, a hierarchical logistic regression analysis was 
utilized to examine whether the three aspects of masculinity predicted CRC screening 
adherence above and beyond the predictive value of variables that have predicted CRC 
screening adherence in prior studies (i.e., race, age, education, physician recommending 
CRC screening, and family/friend recommending CRC screening). Furthermore, logistic 
regression analyses were used to examine the extent to which the three aspects of 
masculinity predicted the receipt of stool blood testing and endoscopic screening. Results 
suggested that none of the three masculinity variables were significantly associated with 
CRC screening adherence. In addition, health beliefs did not mediate the proposed 
relationships between aspects of masculinity and CRC screening adherence, and 
participant characteristics did not moderate relations between certain mediators and 
outcome variables. Potential explanations for study results and future directions are  
  
 
xiii 
discussed. Prospective and longitudinal research studies that recruit participants from 
diverse backgrounds are required to better understand relationships among study 
variables.
  
 
1 
BACKGROUND 
 
Introduction 
Men’s adherence to masculinity norms has been implicated as a risk factor for 
unhealthy behaviors (e.g., drinking to intoxication, having unprotected sex with multiple, 
simultaneous partners) and lack of engagement in healthy behaviors (e.g., blood pressure 
screening, cholesterol screening, wearing protective clothing while in the sun, receipt of 
annual medical and dental exams) (Boman & Walker, 2010; Courtenay, 2000a, 2000b, 
2011; Hammond, Matthews, & Corbie-Smith, 2010; Iwamoto, Cheng, Lee, Takamatsu, 
& Gordon, 2011; Locke & Mahalik, 2005; Mahalik, Lagan, & Morrison, 2006; Mahalik 
et al., 2003; Nicholas, 2000; Pachankis, Westmaas, & Dougherty, 2011; Pleck, 
Sonenstein, & Ku, 1993; Wade, 2009).  Masculinity has been defined as behaviors, 
beliefs, and personality characteristics associated more often with men than women as 
well as characteristics and behaviors that society prescribes and reinforces in men 
(Thompson, Pleck, & Ferrera, 1992).  Rooted in geographical, cultural, and temporal 
environments, diverse masculinities have emerged throughout the United States and the 
world (Connell, 1995; Courtenay, 2011).  Traditional masculinity beliefs and behaviors in 
the United States include the sturdy oak (men should be tough, self-reliant, stoic, and 
confident), no sissy stuff (men should avoid feminine characteristics and behaviors), the 
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big wheel (men should strive for success and status), and give ‘em hell (men should 
embrace aggressiveness, daring, and violence) (Brannon, 1976).  
Numerous qualitative studies have suggested that some men find cancer screening 
examinations involving the rectum (i.e., endoscopy for colorectal cancer [CRC] screening 
or digital rectal examination [DRE] for prostate cancer screening) an affront to their 
masculinity (see Table 1 for quotations from these studies) (Bass et al., 2011; Beeker, 
Kraft, Southwell, & Jorgensen, 2000; Getrich et al., 2012; Goldman, Diaz, & Kim, 2009; 
Harvey & Alston, 2011; Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, Kuzel, 
& Woolf, 2010; Rivera-Ramos & Buki, 2011; Thompson, Reeder, & Abel, 2011; 
Wackerbarth, Peters, & Haist, 2005; Winterich et al., 2009).  However, to the author’s 
knowledge, no quantitative studies have considered the role of masculinity in CRC 
screening adherence.  Unfortunately, current CRC screening rates fall below the 70.5% 
Healthy People 2020 screening objective (U.S. Department of Health and Human 
Services, 2012). 
Research is needed to better understand relationships between men’s masculinity 
norms and CRC screening adherence so that interventions may be developed to reduce 
barriers to screening, improve screening rates, and, ultimately, decrease men’s mortality 
from CRC.  The present study will address this gap in the literature by examining the 
masculinity norms and CRC screening adherence of male veterans aged 51-75 years who 
are at average CRC risk (Levin et al., 2008).  First, the prevalence of CRC, its risk factors 
and warning signs as well as CRC screening techniques, screening rates, and 
characteristics of individuals who are adherent and non-adherent to CRC screening 
guidelines are summarized.  Next, the concept of masculinity, theoretical and empirical 
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support for studying masculinity norms within the context of CRC screening, and 
potential relationships between masculinity norms and colorectal cancer screening 
behaviors are described.  Finally, the study methods, results, and future directions and 
limitations of this research are described.  
 
Colorectal Cancer: Prevalence, Risk Factors, and Warning Signs 
As the third most common cancer diagnosed and the third most common cause of 
cancer deaths among men in the United States, CRC represents a significant public health 
issue (American Cancer Society, 2014a, 2014b).  Compared to women, men are at higher 
risk of being diagnosed with CRC and dying from CRC (Howlader et al., 2011).  From 
2007-2011, 50.6 per 100,000 men received a CRC diagnosis per year and 19.6 per 
100,000 men died from CRC per year, whereas 38.2 per 100,000 women received a CRC 
diagnosis per year and 13.9 per 100,000 women died from CRC per year (National 
Cancer Institute, 2014).  Unfortunately, 60% of CRC cases are diagnosed at an advanced 
stage (American Cancer Society, 2011, 2014a).  It is projected that 132,700 individuals in 
the United States will receive a CRC diagnosis (69,090 men and 63,610 women), and 
49,700 individuals will die from colon or rectal cancers (26,100 men and 23,600 women) 
in 2015 (American Cancer Society, 2015).   
A number of risk factors for CRC have been identified (National Cancer Institute, 
2012b).  Unmodifiable risk factors for CRC include age, family history of CRC, personal 
history of precancerous colon polyps, and certain medical conditions (e.g., ulcerative 
colitis, Crohn’s disease, CRC-linked hereditary syndromes) (National Cancer Institute, 
2012b).  Modifiable risk factors for the disease include obesity, smoking, greater alcohol 
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intake, lack of physical activity, poor diet, and failure to undergo CRC screening 
(National Cancer Institute, 2012b).   
  A variety of symptoms may be indicative of CRC (National Cancer Institute, 
2012a, 2012c).  Although many cases of CRC are asymptomatic, when present, common 
CRC symptoms include blood in the stool, abdominal pain or bloating, narrowing of 
stool, constipation, diarrhea, tenesmus (the sensation that one cannot completely empty 
one’s bowels), or other changes in bowel habits (National Cancer Institute, 2012a, 
2012c).  Other symptoms of CRC include fatigue, vomiting, sudden, unintentional weight 
loss, and a change in one’s appetite (National Cancer Institute, 2012a, 2012c).  
 
Screening for Colorectal Cancer 
Adherence to CRC screening guidelines by eligible U.S. adults has the potential 
to reduce mortality from the disease by approximately half (Brenner, Chang-Claude, 
Seiler, Rickert, & Hoffmeister, 2011; Cafferty, Sasieni, & Duffy, 2009; Citarda, 
Tomaselli, Capocaccia, Barcherini, & Crespi, 2001; Edwards et al., 2010; Levin et al., 
2008; National Cancer Institute, 2000; Thiis-Evensen et al., 1999; Winawer et al., 1997).  
Tests used to identify CRC include colonoscopy, fecal occult blood test (FOBT), fecal 
immunochemical test (FIT), barium enema, flexible sigmoidoscopy, DRE, virtual 
colonoscopy, biopsy, or carcinoembryonic antigen (CEA) assay, a blood test to detect a 
CRC-associated antigen (National Cancer Institute, 2012a, 2012c).  CRC is highly 
curable when detected early (American Cancer Society, 2012b; National Cancer Institute, 
2012d).  In addition, some CRC screening methods can remove precancerous colon 
polyps before they develop into CRC, thereby decreasing incidence and mortality from 
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this disease (American Cancer Society, 2012b; Brenner et al., 2011; Cafferty et al., 2009; 
Citarda et al., 2001; Edwards et al., 2010; Levin et al., 2008; National Cancer Institute, 
2000, 2012d; Thiis-Evensen et al., 1999; Winawer et al., 1997).  
 Recommended CRC screening methods vary according to one’s risk factors for 
the disease.  These risk factors include increasing age, family history of CRC, a history of 
colon polyps, genetic syndromes (e.g., familial adenomatous polyposis, Lynch 
syndrome), and certain medical conditions (e.g., ulcerative colitis, Crohn’s disease) 
(Levin et al., 2008).  Individuals who lack risk factors other than age are at average risk 
for CRC (Levin et al., 2008).  For these individuals, screening begins at age 50 and 
includes the following six options: (1) single-strand DNA (frequency not specified); (2) 
FOBT or FIT each year; (3) flexible sigmoidoscopy every five years; (4) double-contrast 
barium enema every five years; (5) virtual colonoscopy every five years; or (6) 
colonoscopy every ten years (Levin et al., 2008; Smith, Cokkinides, Brooks, Saslow, & 
Brawley, 2010).  Among individuals at increased risk for CRC, colonoscopy is 
recommended for CRC surveillance and this test may begin prior to age 50 (Smith et al., 
2010).  Despite a range of CRC screening options for average-risk individuals, only 
60.2% of American men aged 50 or older are adherent to current CRC screening 
recommendations (American Cancer Society, 2014b).  
 
Characteristics Associated with Colorectal Cancer Screening Adherence and 
Non-adherence 
A number of demographic, personal health, and clinical variables have been 
associated with CRC screening in men and women (Beydoun & Beydoun, 2008; Brouse, 
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Wolf, & Basch, 2008; Centers for Disease Control and Prevention, 2012b; Farmer, 
Bastani, Kwan, Belman, & Ganz, 2008; Friedman, Webb, & Everett, 2004; Guessous et 
al., 2010; Honda, 2004; Jandorf et al., 2010; Kremers, Mesters, Pladdet, van den Borne, 
& Stockbrugger, 2000; Post et al., 2008; Tabbarah, Nowalk, Raymund, Jewell, & 
Zimmerman, 2005; Tessaro, Mangone, Parkar, & Pawar, 2006; Vernon, 1997; Ziegler, 
Schubring-Giese, Buhner, & Kolligs, 2010).  Prior research has consistently found that 
White race and older age (65 years and older) predict CRC screening (Centers for 
Disease Control and Prevention, 2012b).  Additional predictors of CRC screening 
adherence include male gender, greater income, higher educational attainment, health 
insurance coverage, being married, physician recommendation, a family history of CRC, 
perceived family/friend support for CRC screening, adherence to other cancer screening 
guidelines and health protective behaviors, more frequent health care visits, and a 
preventive health orientation (Beydoun & Beydoun, 2008; Brouse et al., 2008; Centers 
for Disease Control and Prevention, 2012b; Farmer et al., 2008; Friedman et al., 2004; 
Guessous et al., 2010; Honda, 2004; Jandorf et al., 2010; Kremers et al., 2000; Post et al., 
2008; Tabbarah et al., 2005; Tessaro et al., 2006; Vernon, 1997; Ziegler et al., 2010).  
Mixed associations have been obtained between medical co-morbidities and CRC 
screening (Fleming, Schoenberg, Tarasenko, & Pearce, 2011; Lukin et al., 2012).  
Although male gender has predicted CRC screening in prior studies, researchers have 
found that men’s self-reported colonoscopy rates were inflated and that over-reporting of 
colonoscopy by men may in fact account for the gender differences in CRC screening 
rates found in these studies (Griffin et al., 2009).   
  
 
7 
Cognitive variables also have been predictive of CRC screening behavior.  For 
example, perceived risk of CRC and self-efficacy for CRC screening test completion 
have been positively associated with CRC screening adherence (Halbert et al., 2011; 
Kremers et al., 2000; Myers et al., 1994; Tessaro et al., 2006).  However, the relationship 
between perceived risk of CRC and CRC screening has been inconsistent (Manne et al., 
2003).  Lack of knowledge of both CRC and CRC screening also has been associated 
with decreased CRC screening (Beeker et al., 2000; Berkowitz, Hawkins, Peipins, White, 
& Nadel, 2008; Friedemann-Sanchez, Griffin, & Partin, 2007; Jones, Devers, et al., 2010; 
Jones, Woolf, et al., 2010; O'Malley, Beaton, Yabroff, Abramson, & Mandelblatt, 2004).  
In addition, CRC test requirements (e.g., collecting stool samples, test preparation for 
endoscopy, including food restriction and consuming the preparation laxative) have been 
noted as perceived barriers to CRC screening (Beeker et al., 2000; Denberg et al., 2005; 
Jones, Devers, et al., 2010).  Low health literacy, greater cancer fatalism, and lack of trust 
in one’s physician also have been associated with decreased CRC screening adherence 
(Jones, Devers, et al., 2010; O'Malley et al., 2004; Shelton, Jandorf, Ellison, Villagra, & 
DuHamel, 2011). 
A growing body of research has examined the role of affect and emotions in CRC 
screening behavior (Consedine, Magai, Krivoshekova, Ryzewicz, & Neugut, 2004; 
Consedine, Reddig, Ladwig, & Broadbent, 2011; Manne et al., 2003; Paddison & Yip, 
2010; Power et al., 2008; Rawl, Menon, Champion, Foster, & Skinner, 2000; Robinson et 
al., 2011; Sandberg & Conner, 2009; Waller, Bartoszek, Marlow, & Wardle, 2009).  Fear 
of cancer and fear of pain related to screening have been inversely related to CRC 
screening (Farraye et al., 2004; Feeley, Cooper, Foels, & Mahoney, 2009; Friedemann-
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Sanchez et al., 2007; Jandorf et al., 2010; Jones, Devers, et al., 2010; Weinberg, Turner, 
Wang, Myers, & Miller, 2004).  In addition, concern about one’s body being exposed to 
others and negative attitudes toward CRC screening tests and test preparation have been 
found to be negatively associated with screening (Beeker et al., 2000; Denberg et al., 
2005; Farraye et al., 2004; Feeley et al., 2009; Friedemann-Sanchez et al., 2007; Janz, 
Wren, Schottenfeld, & Guire, 2003; Jones, Devers, et al., 2010; Jones, Woolf, et al., 
2010).  Greater embarrassment has been consistently associated with both lower stage of 
readiness to complete CRC screening and decreased CRC screening behaviors 
(Consedine, Ladwig, Reddig, & Broadbent, 2011; Paddison & Yip, 2010; Rawl et al., 
2000).  On the other hand, anticipated regret (i.e., regret if one were to forgo CRC 
screening and later developed CRC) and cancer-related worry have been positively 
related to intentions to complete CRC screening (Brenes & Paskett, 2000; Ferrer et al., 
2011; Power et al., 2008; Wardle et al., 2000).  Whereas anticipated regret has been 
unrelated to CRC screening behavior (Power et al., 2008), cancer-related worry has 
shown negative associations with this behavior (Robinson et al., 2011).  
Although researchers have identified demographic, cognitive, and affective 
factors as predictors of CRC screening behavior, these studies have failed to examine the 
potential role of masculinity norms in men’s screening behavior.  Although not yet tested, 
a conceptual framework which integrates previously demonstrated predictors of CRC 
screening behavior (e.g., demographics, cognitions, emotions), physician and systems-
level characteristics, and aspects of masculinity and gender role beliefs has been created 
(Christy, Mosher, & Rawl, 2014). Even though qualitative studies have shown that some 
men believe that cancer screening involving the rectum violates masculinity norms (Bass 
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et al., 2011; Beeker et al., 2000; Getrich et al., 2012; Goldman et al., 2009; Harvey & 
Alston, 2011; Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, et al., 2010; 
Rivera-Ramos & Buki, 2011; Thompson et al., 2011; Wackerbarth et al., 2005; Winterich 
et al., 2009), to the author’s knowledge, no quantitative examination of the role of 
masculinity norms in CRC screening adherence has been conducted. 
 
Masculinity 
 Masculinity has been conceptualized as male characteristics based on commonly 
found differences between males and females as well as the characteristics that society 
imposes and emphasizes in males (Thompson et al., 1992).  In the United States, there are 
various types of masculinities that are adopted by diverse groups of men (e.g., based 
upon sexual orientation, geographic region, race, socioeconomic status, time period) 
(Campbell & Bell, 2000; Courtenay, 2011; Levant, Majors, & Kelley, 1998).  However, 
most American conceptualizations of traditional masculinity norms include the following 
ideals: emotional control, non-relational attitudes toward sexuality, power over women, 
winning, dominance, primacy of work, avoidance of femininity, pursuit of status, 
violence/aggression, risk-taking, self-reliance, and disdain for gay individuals (or 
heterosexual self-presentation) (Brannon, 1976; Mahalik et al., 2003; Parent & Moradi, 
2009; Walker, Tokar, & Fischer, 2000).  Gender role conflict (or stress) occurs when a 
man who holds masculinity beliefs is confronted by a situation in which those 
masculinity beliefs are or may be breached (Eisler, Skidmore, & Ward, 1988; O'Neil, 
2008).  Gender role conflict and adherence to masculinity norms have been found to vary 
as a function of race and socioeconomic status (SES) (Abreu, Goodyear, Campos, & 
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Newcomb, 2000; Connell, 1995; Courtenay, 2011; Courtenay, 2000a; Jakupcak, Lisak, & 
Roemer, 2002; Levant & Majors, 1997; Levant et al., 1998; Levant et al., 2003; Mahalik 
et al., 2003; Norwalk, Vandiver, White, & Englar-Carlson, 2011; Stillson, O'Neil, & 
Owen, 1991).  Specifically, African-American and Hispanic men generally have reported 
higher levels of gender role conflict and traditional masculinity norms compared to 
Caucasian men (Abreu et al., 2000; Levant & Majors, 1997; Levant et al., 1998; Norwalk 
et al., 2011).  In addition, men from lower SES backgrounds are more likely than those of 
higher SES to adhere to traditional masculinity norms and experience gender role conflict 
(Connell, 1995; Courtenay, 2000a, 2011; Mahalik et al., 2003; Stillson et al., 1991).  
Masculinity beliefs have been predictive of perceived barriers to health care use 
and degree of engagement in health-promoting behaviors (Boman & Walker, 2010; 
Courtenay, 2000a, 2000b, 2011; Mahalik & Burns, 2011; Mahalik, Burns, & Syzdek, 
2007; Nicholas, 2000; Pleck et al., 1993; Springer & Mouzon, 2011).  Men who endorse 
higher levels of masculinity have been found to be less likely to engage in preventive 
health care (e.g., prostate cancer examination, flu shot) compared to men with moderate 
levels of masculinity (Springer & Mouzon, 2011).  In addition, endorsement of 
masculinity norms, coupled with higher levels of perceived barriers to performance of 
heart-healthy behaviors (e.g., healthy diet, regular exercise, medical check-ups and tests), 
have been associated with decreased likelihood of performing these behaviors (Mahalik 
& Burns, 2011).    
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Evidence for the Role of Masculinity in CRC Screening 
Although no known quantitative research has been conducted to examine the 
relationship between masculinity norms and CRC screening adherence, qualitative 
evidence supports the possibility that adherence to masculinity norms may influence 
some men’s willingness to undergo endoscopic CRC screening (see Table 1) (Bass et al., 
2011; Beeker et al., 2000; Getrich et al., 2012; Goldman et al., 2009; Harvey & Alston, 
2011; Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, et al., 2010; Rivera-
Ramos & Buki, 2011; Thompson et al., 2011; Wackerbarth et al., 2005; Winterich et al., 
2009).  For example, an African-American man reported “…probing around in my 
rectum . . . [is] treading on my masculinity” (Beeker et al., 2000, p. 268).  Similarly, 
another African-American man stated “…biggest fear…someone placing something in 
my rectum, that’s how most men are” (Winterich et al., 2009, p. 6).  When describing a 
friend who had undergone CRC screening, a Hispanic man reported “[My friend] told me 
he had lost his manhood.  So, we must be very careful with that because people think that 
they lose their manhood” (Jones, Devers, et al., 2010, p. 512).  Yet another man asserted 
“I think it’s problematic for men…especially homophobic men…they think you let 
someone do that to you, you ain’t a real man” (Jones, Devers, et al., 2010, p. 512).  
Identifying colonoscopy specifically, one man noted “…you know, guys are usually 
reluctant to have colonoscopies because I guess it is a male ego thing you know, having 
something inserted into your rectum” (Bass et al., 2011, p. 124).  These quotations 
highlight themes of masculinity that have been revealed by a number of men in 
qualitative studies on CRC screening.  
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A few quantitative studies of cancer screening and prevention have broached the 
topics of masculinity and/or concerns about screening involving the rectum (Jones, 
Devers, et al., 2010; Millar & Houska, 2007; Paiva, Motta, & Griep, 2011).  In a study of 
intention to perform self-examination for skin cancer, men and women with low levels of 
masculinity were more likely to report intention to perform the behavior than those with 
high levels of masculinity (Millar & Houska, 2007).  To this author’s knowledge, only 
one quantitative study has evaluated the role of masculinity in cancer screening involving 
the rectum (Paiva et al., 2011).  This study focused on prostate cancer screening and used 
a single item to assess perceptions of masculinity with respect to prostate cancer 
screening (Paiva et al., 2011).  Researchers found that more than one-third of participants 
reported they agreed with the following statement: “the prostate examination can affect 
masculinity” (34.4%) (Paiva et al., 2011).  In a study of CRC screening decision-making 
among both men and women, the statement “I do not want a tube inserted in my rectum” 
was ranked as one of the top five barriers to colonoscopy and sigmoidoscopy (Jones, 
Devers, et al., 2010).  This statement was the top-ranked barrier for those who had never 
been screened and was ranked second by those overdue for screening (Jones, Devers, et 
al., 2010).  However, it is unclear whether masculinity beliefs influenced men’s decisions 
regarding CRC screening (Jones, Devers, et al., 2010).   
 
Proposed Relationships between Aspects of Masculinity and Colorectal Cancer Screening 
 Given that some men have voiced concerns that cancer screening tests involving 
the rectum (i.e., endoscopy, DRE) are an affront to masculinity norms (Bass et al., 2011; 
Beeker et al., 2000; Getrich et al., 2012; Goldman et al., 2009; Harvey & Alston, 2011; 
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Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, et al., 2010; Rivera-Ramos & 
Buki, 2011; Thompson et al., 2011; Wackerbarth et al., 2005; Winterich et al., 2009), it 
was proposed that three masculinity norms (i.e., heterosexual self-presentation, risk-
taking, and self-reliance) would be inversely related to CRC screening adherence among 
men at average CRC risk.  First, it was hypothesized that heterosexual self-presentation 
would be inversely related to CRC screening adherence.  According to masculinity theory 
(Brannon, 1976; Courtenay, 2011), masculine, heterosexual men should disdain 
homosexuality, fear gay individuals (especially gay men), and preserve their own 
heterosexuality.  Qualitative research supports this notion with men emphasizing their 
concern that cancer screening involving the rectum could affect their sexuality or be 
indicative of homosexuality (Getrich et al., 2012; Harvey & Alston, 2011; Holt et al., 
2009; Jones, Devers, et al., 2010; Thompson et al., 2011; Winterich et al., 2011).  If a 
man visits his provider and receives a CRC screening recommendation, colonoscopy is 
the most likely test to be recommended (Klabunde et al., 2009; McQueen et al., 2009).  It 
is unlikely that a patient will be fully informed about all screening test options (Klabunde 
et al., 2009; McQueen et al., 2009), and those men who would be more comfortable with 
FOBT or FIT (i.e., men adhering to the heterosexual self-presentation masculinity norm) 
may go unscreened if only offered screening methods involving penetration of the rectum 
(McQueen et al., 2009).   
 Second, it was hypothesized that the masculinity norm of risk-taking would be 
inversely related to CRC screening adherence.  Endorsement of the risk-taking 
masculinity norm has been associated with performance of risky health behaviors (e.g., 
smoking, drinking to intoxication) (Mahalik et al., 2003), but has not been examined with 
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regard to CRC screening adherence.  According to masculinity theory (Courtenay, 2000a, 
2000b, 2011; Nicholas, 2000), men who hold risk-taking beliefs may not feel that CRC or 
other diseases are a threat to their well-being.  In addition, masculinity theory suggests 
that these individuals may not be concerned about their health, attend preventive health 
services, or undergo CRC screening (Courtenay, 2000a, 2000b, 2011; Nicholas, 2000).  
For example, a study of skin cancer reduction behaviors (i.e., sunscreen usage and skin 
self-examination) included a masculinity measure with an item addressing risk-taking 
beliefs (Bem, 1974; Millar & Houska, 2007).  The results of this study indicated that 
individuals endorsing higher levels of masculinity were: 1) less likely to report distress 
about skin cancer risks and 2) more likely to report being in better health compared to 
individuals with lower levels of masculinity beliefs (Millar & Houska, 2007).  
Furthermore, individuals reporting higher levels of masculinity reported lower levels of 
intention to engage in skin cancer self-examination (Millar & Houska, 2007). 
In the current study, it was hypothesized that the relationship between risk-taking 
and CRC screening adherence would be partially mediated by cancer fear.  Specifically, 
based on masculinity theory (Courtenay, 2000a, 2000b, 2011), it was predicted that 
greater risk-taking would be associated with lower levels of cancer fear, which, in turn, 
would be associated with a lower likelihood of CRC screening adherence.  According to 
masculinity theory (Courtenay, 2000a, 2000b, 2011; Nicholas, 2000), masculinity ideals 
such as risk-taking bolster the belief that men should deny vulnerability to diseases.  
Thus, the theory predicts an inverse association between risk-taking beliefs and cancer 
fear.  Additionally, in a study of prostate cancer screening, trait fear was positively 
associated with screening behavior (Consedine, Morgenstern, Kudadjie-Gyamfi, Magai, 
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& Neugut, 2006).  Prior research has demonstrated mixed results with regard to the 
relationship between cancer fear and cancer screening in primarily female samples 
(Consedine et al., 2004; Hay, Buckley, & Ostroff, 2005).  However, in a review of the 
literature on breast cancer screening, Consedine and colleagues (2004) found that general 
cancer fear may be associated with increases in cancer screening, whereas fear of specific 
aspects of screening or the specific disease type (e.g., belief that screening is painful or 
embarrassing, fears of specific cancer treatments if diagnosed with cancer) are inversely 
associated with cancer screening.  These researchers suggested that “acting to reduce 
generalized cancer worry may, in many cases, involve engaging in a screening behavior 
as the individual seeks to reduce their anxiety” (Consedine et al., 2004, p. 507).  In the 
present study, general cancer fear was measured and, therefore, a positive association 
between cancer fear and CRC screening adherence was hypothesized.   
It was also hypothesized that age would moderate the strength of the relationship 
between cancer fear and CRC screening adherence such that the relationship between 
cancer fear and CRC screening would be weaker with increasing age.  In studies of 
cancer survivors, age has been inversely related to fear of cancer recurrence (Crist & 
Grunfeld, 2013; Lebel, Beattie, Arès, & Bielajew, 2013; Ziner et al., 2012).  Additionally, 
increasing age has been found to be inversely related to fear of death (Cicirelli, 2006).  
Furthermore, in a study of adult women aged 30 to 74, older women reported less breast 
cancer worry than younger women (Harris et al., 1991).  Thus, although the current study 
was focused upon men, increasing age was predicted to be inversely related to fear of 
cancer, rendering it a weak predictor of CRC screening in older age groups. 
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Third, it was hypothesized that self-reliance would be inversely related to CRC 
screening adherence.  Masculinity theory suggests that men who endorse self-reliance 
ideals may not have a consistent health care provider and, therefore, may not have an 
opportunity to receive a recommendation for CRC screening (Boman & Walker, 2010; 
Courtenay, 2000a, 2000b, 2011; Hammond, Matthews, & Corbie-Smith, 2010; Iwamoto 
et al., 2011; Locke & Mahalik, 2005; Mahalik et al., 2006; Mahalik et al., 2003; 
Nicholas, 2000; Pachankis et al., 2011; Pleck et al., 1993; Wade, 2009).  These 
individuals may not believe that “real men” see primary care providers (PCPs) for 
preventive care or undergo cancer screening.  Indeed, individuals who endorse self-
reliance ideals may not trust physicians due to the belief that one should not ask for help 
and their infrequent interactions with health care providers.  Lack of trust in one’s 
physician and the medical system has been indicated as a barrier to CRC screening and 
other preventive health services, especially among individuals from ethnic minority 
groups (Fyffe, Hudson, Fagan, & Brown, 2008; Greiner, Born, Nollen, & Ahluwalia, 
2005; Hammond, Matthews, Mohottige, Agyemang, & Corbie-Smith, 2010; Jones, 
Devers, et al., 2010).  Thus, it was hypothesized that the relationship between self-
reliance and CRC screening adherence would be partially mediated by trust in PCP.  
Specifically, it was expected that greater self-reliance would be associated with lower 
levels of trust in PCP, which, in turn, would be associated with a lower likelihood of 
CRC screening adherence.   
Length of patient-provider relationship and race were hypothesized to influence 
the relationship between trust in one’s physician and CRC screening adherence.  From a 
theoretical standpoint, trust in PCP has been conceptualized as stemming from both 
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interpersonal trust through multiple interactions with a PCP as well as social trust which 
includes trust of healthcare institutions (Pearson & Raeke, 2000).  Described as “patient 
trust theory,” patients’ trust in their PCP is “built through repeated interactions through 
which expectations about a person's trustworthy behavior can be tested over time” 
(Pearson & Raeke, 2000, p. 510).  Length of the patient-provider relationship has been 
positively correlated with trust in PCP (r = 0.27) (Kao, Green, Davis, Koplan, & Cleary, 
1998; Mainous, Baker, Love, Gray, & Gill, 2001).  In addition, trust in PCP has been 
predictive of the receipt of preventive health services (i.e., mammography, flu vaccine, 
eye examination) (Parchman & Burge, 2004).  Furthermore, ethnic minority patients have 
been found to report lower levels of trust in PCPs relative to White patients (Boulware, 
Cooper, Ratner, LaVeist, & Powe, 2003; Doescher, Saver, Franks, & Fiscella, 2000; 
Halbert, Armstrong, Gandy, & Shaker, 2006; Musa, Schulz, Harris, Silverman, & 
Thomas, 2009).  In one study, race (African American vs. White) and trust in PCP did not 
interact to predict receipt of prostate-specific antigen tests (Musa et al., 2009).  However, 
as indicated by ethnic minority men in numerous qualitative studies of cancer screenings 
involving the rectum, endoscopic CRC screening was considered to be invasive and an 
affront to masculinity norms (Bass et al., 2011; Beeker et al., 2000; Getrich et al., 2012; 
Harvey & Alston, 2011; Holt et al., 2009; Rivera-Ramos & Buki, 2011; Winterich et al., 
2011; Winterich et al., 2009). Therefore, trust in PCP may be especially important in 
overcoming these barriers to CRC screening among ethnic minority men.  Thus, it was 
hypothesized that race and length of patient-provider relationship would moderate the 
strength of the relationship between trust in PCP and CRC screening adherence.  
Specifically, it was expected that the relationship between trust in PCP and CRC 
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screening would be stronger among African Americans compared to Whites and with 
increasing length of patient-provider relationship.  
As previously noted, endoscopic screening (i.e., colonoscopy, sigmoidoscopy) 
may be difficult for some men due to the perceived breach of masculinity norms (Bass et 
al., 2011; Beeker et al., 2000; Getrich et al., 2012; Goldman et al., 2009; Harvey & 
Alston, 2011; Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, et al., 2010; 
Rivera-Ramos & Buki, 2011; Thompson et al., 2011; Wackerbarth et al., 2005; Winterich 
et al., 2009).  Due to the invasive nature of endoscopic procedures, masculinity variables 
may be differentially associated with stool blood test (e.g., FOBT or FIT) versus 
endoscopic screening modalities (i.e., sigmoidoscopy or colonoscopy).  Men perceive 
colonoscopy to be more invasive than sigmoidoscopy (Friedemann-Sanchez et al., 2007).  
Although colonoscopy is a commonly-used method of CRC screening at the proposed 
setting of this study (Roudebush Veterans Affairs Medical Center [VAMC] in 
Indianapolis, Indiana), few patients at Roudebush VAMC currently receive 
sigmoidoscopy (Rao, personal communication, January 18, 2013).  Due to the invasive 
nature of sigmoidoscopy and colonoscopy, these two screening modalities were 
combined into a single outcome of “endoscopy.”  Due to the non-invasive nature and 
identical testing schedules of FOBT and FIT, these two stool blood tests were combined 
into a single outcome of “stool blood test.”  In the present study, CRC screening 
adherence was considered as both a combined and separate outcome (i.e., adherence to 
stool blood test [FOBT or FIT] or endoscopy [sigmoidoscopy in the past 5 years or 
colonoscopy in the past 10 years]).
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PRESENT STUDY 
 
The current study aims to understand associations between aspects of masculinity, 
health beliefs, and CRC screening adherence in 350 male Veterans Affairs (VA) primary 
care patients aged 51-75 years with average CRC risk.  This study targeted adult males 
who were age-appropriate and at average risk for CRC, including stool blood test (FOBT 
or FIT) or endoscopy (sigmoidoscopy or colonoscopy) procedures (Levin et al., 2008).  
The setting of the Roudebush VAMC in Indianapolis, Indiana was selected, as there are a 
large number of men utilizing primary care at this setting who have access to stool blood 
test (FOBT or FIT) and endoscopy (sigmoidoscopy or colonoscopy) services regardless 
of health insurance status.  Colonoscopy, FOBT, and sigmoidoscopy are the most 
commonly utilized screening modalities in the national VA Health Administration (Long 
et al., 2012).  In addition, since 2005, VA hospitals across the country have attempted to 
increase CRC screening among veterans as part of a CRC diagnosis and care quality 
improvement strategy (Jackson et al., 2010). 
In a recent study considering data from more than 36,000 veterans nationwide, 
more than 80% of eligible veterans were adherent to CRC screening recommendations 
(Long et al., 2012).  Of those veterans adherent to current CRC screening 
recommendations, nearly 72% received colonoscopy in the past 10 years, 24% completed 
FOBT in the past year, and nearly 4% received sigmoidoscopy in the past 5 years (Long 
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et al., 2012).  The Roudebush VAMC has CRC screening rates slightly lower than 
national VA Health Administration rates; however, these screening rates are still higher 
than the CRC screening adherence rates found in the general United States population 
(Haggstrom, personal communication, November 1, 2012).  Given that unscreened VA 
patients have access to CRC screening services and are likely to have received a 
recommendation for CRC screening from their PCP, they are an especially unique 
population to study.  
Primary Objectives. The aims and hypotheses of the present study are as follows:  
Aim 1: Examine the extent to which three aspects of masculinity (i.e., heterosexual self-
presentation, risk-taking, and self-reliance) are associated with CRC screening adherence 
(i.e., stool blood test [FOBT or FIT] in the past year or endoscopy [i.e., sigmoidoscopy in 
the past 5 years or colonoscopy in the past 10 years]) in male VA primary care patients 
aged 51-75 while controlling for age, race, and education level.  
Hypothesis 1.1: Controlling for age, race, and education level, three aspects of 
masculinity (i.e., heterosexual self-presentation, risk-taking, and self-reliance) 
will be inversely associated with CRC screening adherence (i.e., stool blood test 
[FOBT or FIT] in the past year or endoscopy [sigmoidoscopy in the past 5 years 
or colonoscopy in the past 10 years]). 
 
Aim 2: Examine potential mediators of the relationship between aspects of masculinity 
(i.e., risk-taking and self-reliance) and CRC screening adherence (i.e., stool blood test 
[FOBT or FIT] in the past year or endoscopy [sigmoidoscopy in the past 5 years or 
colonoscopy in the past 10 years]) in male VA primary care patients aged 51-75 while 
controlling for age, race, and education level.    
Hypothesis 2.1: Controlling for age, race, and education level, cancer fear will 
partially mediate the relationship between risk-taking and CRC screening 
adherence (i.e., stool blood test [FOBT or FIT] in the past year or endoscopy 
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[sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years]) in male 
VA primary care patients aged 51-75.   
   
Hypothesis 2.2: Controlling for age, race, and education level, trust in PCP will 
partially mediate the relationship between self-reliance and CRC screening 
adherence (i.e., stool blood test [FOBT or FIT] in the past year or endoscopy 
[sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years]) in male 
VA primary care patients aged 51-75.    
    
Aim 3: Examine potential moderators of relationships specified in the models proposed in 
Aim #2 while controlling for demographic covariates.  
Hypothesis 3.1: Controlling for race and education level, age will moderate the 
strength of the relationship between cancer fear and CRC screening adherence 
such that the relationship between cancer fear and CRC screening will be weaker 
with increasing age.  
 
Hypothesis 3.2: Controlling for age and education level, race will moderate the 
strength of the relationship between trust in PCP and CRC screening adherence 
such that the relationship between trust in PCP and CRC screening will be 
stronger among African Americans compared to Whites. 
 
Hypothesis 3.3: Controlling for age, race, and education level, length of patient-
provider relationship will moderate the strength of the relationship between trust 
in PCP and CRC screening adherence such that the relationship between trust in 
PCP and CRC screening will be stronger with increasing length of patient-
provider relationship. 
 
Aim 4: Examine the extent to which three aspects of masculinity (i.e., heterosexual self-
presentation, risk-taking, and self-reliance) are associated with CRC screening behavior, 
controlling for the effects of variables recognized as significant predictors of CRC 
screening in prior research (i.e., White race, older age, higher education level, physician 
recommending CRC screening, family and friends recommending CRC screening).   
Hypothesis 4.1: Aspects of masculinity (i.e., heterosexual self-presentation, risk-
taking, and self-reliance) will predict CRC screening adherence above and 
beyond the predictive value of race, age, education, physician recommending 
CRC screening, and family/friend recommending CRC screening.    
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Aim 5:  Examine associations between three aspects of masculinity (i.e., heterosexual 
self-presentation, risk-taking, and self-reliance) and CRC screening status (i.e., non-
adherence, adherence with stool blood test [FOBT or FIT in the past year], or adherence 
with endoscopy [sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years]) 
in male VA primary care patients aged 51-75 while controlling for age, race, and 
education level.
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METHODS 
 
Participant Selection 
A sample of 350 male veterans who were at average CRC risk and receiving care 
at the Roudebush VAMC in primary care clinics were enrolled in the study.  Eligibility 
criteria included male gender, age 51-75, average CRC risk (i.e., no prior colon or rectal 
cancer diagnoses or diagnoses of a medical condition which would place the individual at 
increased risk for CRC such as Crohn’s disease, ulcerative colitis, familial adenomatous 
polyposis, or Lynch syndrome based upon self-report and medical record review, and no 
prior CRC diagnoses in two or more first-degree relatives or in a first-degree relative 
prior to age 60 based upon self-report and medical record review), able to read and write 
in English, no serious cognitive impairment, and scheduled for an upcoming appointment 
in the primary care clinic with either a PCP (e.g., physician or nurse practitioner) or a 
registered nurse (RN).   
Two hundred and thirty-three of the study participants (67%) were adherent to 
CRC screening recommendations (i.e., had a stool blood test [FOBT or FIT] in the past 
year, a sigmoidoscopy in the past 5 years, or a colonoscopy in the past 10 years), and 117 
were non-adherent to these recommendations.  Originally, the dissertation proposal had 
specified that 150 individuals would be adherent to CRC screening recommendations and 
150 individuals would be non-adherent for a total sample size of 300 participants.  
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However, the total sample size was increased to 350 participants in order to increase 
statistical power for the proposed analyses.  In addition, the proposal specified that after 
reaching the target sample of participants adherent to CRC screening (n = 150), 
individuals would be ineligible for this study if they were currently adherent to CRC 
screening recommendations.  However, given the high rates of CRC screening among 
veterans accessing primary care services as well as lower rates of consent among those 
who were non-adherent, the sample of 150 adherent veterans was achieved more rapidly 
than the recruitment of those non-adherent to CRC screening guidelines.  Due to 
methodological concerns (i.e., confounding time of recruitment with adherence status), it 
was decided that individuals from both groups (i.e., adherent and non-adherent) would 
continue to be consented until the total sample size of 350 was reached.   
 
Recruitment Procedures 
 The electronic medical records of male veterans aged 51-75 who were scheduled 
for an upcoming primary care appointment to see their PCP or an RN at Roudebush 
VAMC were reviewed for CRC screening adherence and history of a CRC diagnosis.  
First, patient gender, age, and absence of a personal history of CRC were confirmed via 
medical record in order to identify male veterans between the ages of 51 and 75 who may 
be eligible for the study.  Adherence to endoscopy [colonoscopy or sigmoidoscopy] or 
stool blood test [FOBT or FIT] recommendations (e.g., stool blood test [FOBT or FIT] in 
the past year or endoscopy [sigmoidoscopy in the past 5 years or colonoscopy in the past 
10 years]) was noted based upon the date of the participant’s last FOBT, FIT, 
sigmoidoscopy, or colonoscopy (if applicable) in the medical records.  Individuals were 
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considered CRC screening adherent if they had completed an FOBT or FIT in the past 
year, a sigmoidoscopy in the past 5 years, or a colonoscopy in the past 10 years; CRC 
screening adherence was coded as “yes” or “no.”  While recognizing that there are 
multiple screening modalities for those at average risk for the disease (Levin et al., 2008), 
almost all U.S. veterans adherent to CRC screening recommendations receive FOBT, 
colonoscopy, or sigmoidoscopy (Long et al., 2012).  In addition, providers at Roudebush 
VAMC have recently begun using FIT (Rao, personal communication, January 18, 2013). 
Thus, only the performance of these screening behaviors (i.e., stool blood test [FOBT or 
FIT] or endoscopy [sigmoidoscopy or colonoscopy]) were considered to be indicative of 
CRC screening adherence during the review of patients’ medical records.   
Individuals were consecutively approached in the primary care clinic waiting 
room at the Roudebush VAMC before or after their PCP visit.  The informed consent 
process occurred in either a private area of the primary care clinic, away from other 
patients in the primary care clinic waiting room, or in a clinic examination room.  A 
trained project coordinator or research assistant (RA) described the study, reviewed the 
consent and authorization forms, answered questions, and invited veterans to participate.  
During the informed consent process, the project coordinator or RA asked the participant 
to verbalize his understanding of the study.  If the veteran was unable to clearly describe 
the study, he was considered ineligible due to likely cognitive impairment or language 
difficulties.  In addition, via a paper questionnaire, the veteran was asked if he: 1) had 
been diagnosed with either colon or rectal cancer, Crohn’s disease, ulcerative colitis, 
familial adenomatous polyposis, Lynch syndrome, or colon polyps in the past, and 2) had 
a first-degree relative who had been diagnosed with CRC.  Those with a familial history 
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of CRC indicated whether a first-degree relative had been diagnosed with CRC prior to 
the age of 60 and the number of first-degree relatives who had been diagnosed with CRC.  
Veterans providing affirmative responses to any of the personal health questions and 
those having two or more first-degree relatives with a history of CRC or a first-degree 
relative with a diagnosis of CRC prior to age 60 were considered to be at high risk for 
CRC and, thus, were ineligible for the study.  This medical history information was 
obtained via paper questionnaire so that the confidentiality of the patient’s medical 
history was retained in the primary care clinic waiting room.  The screening questionnaire 
required approximately 3 minutes to complete.  Interested, eligible veterans signed the 
informed consent and HIPAA authorization form prior to study participation. 
 
Data Collection Procedures 
In order to minimize the impact of the study on the primary care clinic flow, 
following informed consent and HIPAA authorization, the paper survey could be 
completed before, during, and/or immediately after a clinic visit.  The survey required 
approximately 14 minutes to complete.  The project coordinator or RA was available to 
answer participants’ questions in the primary care clinic waiting room.  After completing 
the survey, the patient returned the survey to the project coordinator or RA.  At that time, 
the RA or project coordinator checked the questionnaire for omitted item responses.  If 
there were omissions, the research team member asked the participant whether he 
intended to skip the item. 
If the participant was unable to complete the survey while in clinic due to time 
constraints, he was given an addressed, stamped envelope to complete the survey at home 
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and return the survey to the project coordinator.  If the survey was not returned within 14 
days, the project coordinator or RA called the participant to remind him to complete and 
return the survey.  If the survey was not returned within 14 days of the reminder phone 
call, the project coordinator or RA once again called the participant to remind him to 
complete and return the survey to the research team.  Upon completion, the participant 
either hand-delivered (in the case of in-clinic completion) or mailed (in the case of at-
home completion) the survey to the project coordinator or RA, and the participant was 
given a $10 Walmart gift card.  In the case of individuals who completed their survey at 
home, their gift card was sent via US mail after the survey had been returned to the 
research team.  The project coordinator collected the following information from the 
medical records after completion of informed consent and HIPAA authorization forms: 1) 
the date of first visit to the PCP, 2) the date of last colonoscopy, sigmoidoscopy, FOBT, 
and/or FIT (if applicable), 3) medical diagnoses indicative of increased CRC risk (i.e., 
personal history of colon or rectal cancer, Crohn’s disease, ulcerative colitis, familial 
adenomatous polyposis, Lynch syndrome, or colon polyps in the past, or two or more 
first-degree relatives who have been diagnosed with CRC or a first-degree relative who 
has been diagnosed with CRC prior to age 60), 4) zip code, and 5) PCP name.   
 
Measures 
Eligibility was assessed via medical record review and self-report. The self-report 
screening survey included an assessment of personal health and family health diagnoses 
which place one at higher risk for CRC to assess for eligibility (see Appendix A) (Centers 
for Disease Control and Prevention, 2006; Rawl et al., under revision; Rawl et al., 2000; 
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Rawl et al., 2005).  Individuals identified as being at high risk of CRC were ineligible for 
the study.  Once enrolled, participants were asked to complete a paper survey (see 
Appendix B). The survey included an assessment of demographic characteristics, 
personal health characteristics, health experiences, trust in PCP, adherence to masculinity 
norms, and cancer-related fear.  The personal health characteristics and health experience 
measures have been utilized in a large randomized controlled trial which investigated 
CRC screening adherence following receipt of two CRC screening interventions 
delivered in primary care (Christy et al., 2013; Rawl et al., under revision; Rawl et al., 
2012) as well as studies examining CRC screening adherence in those at increased risk 
for the disease (Rawl et al., under review; Rawl et al., 2000; Rawl et al., 2005).  Measures 
of trust in PCP, adherence to masculinity norms, and cancer-related fear have been well-
validated (Champion et al., 2004; Dugan, Trachtenberg, & Hall, 2005; Parent & Moradi, 
2009; Parent & Moradi, 2011; Parent, Moradi, Rummell, & Tokar, 2011).  
 Demographic Characteristics. Seven items were used to assess demographic 
information, including age, race, marital status, employment status, income, health 
insurance status, and education (Centers for Disease Control and Prevention, 2011; 
Mosher et al., 2012).  With the individual’s permission, the following information was 
collected from his medical record: length of patient-provider relationship (first visit with 
current PCP subtracted from date of consent), CRC screening adherence, CRC screening 
test modality completed (if applicable), and CRC risk factors (personal history of colon 
or rectal cancer, Crohn’s disease, ulcerative colitis, familial adenomatous polyposis, 
Lynch syndrome, or colon polyps in the past or having a close family relative who had 
been diagnosed with CRC prior to age 60 or two or more close family relatives who had 
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been diagnosed with CRC).  Although the participant may have been seen by an RN 
during the current visit, the length of his relationship with his PCP was obtained rather 
than the length of his relationship with the RN because the PCP was likely to be the 
provider referring the participant for CRC screening.  Adherence to colonoscopy, 
sigmoidoscopy, or FOBT/FIT recommendations (i.e., colonoscopy in the past 10 years, 
sigmoidoscopy in the past 5 years, or FOBT or FIT in the past year) was also collected 
based upon the date of the participant’s last colonoscopy, sigmoidoscopy and/or stool 
blood test [FOBT or FIT] (if applicable).   
 Health Information and Behaviors. Sixteen items assessed patients’ personal 
cancer history, whether they had a distant relative, friend, or co-worker who had been 
diagnosed with CRC, CRC screening behaviors, and prior recommendations for CRC 
screening from a physician, family member, or friend.  The majority of these questions 
were used in an NCI-funded randomized controlled trial examining CRC screening 
adherence among primary care patients (Christy et al., 2013; Rawl et al., under revision; 
Rawl et al., 2012) and utilize “yes” or “no” responses.  The CRC screening behavior 
items were modified from measures developed by Rawl and colleagues (2000, 2005, 
2012, under revision, under review).  In the original studies, these items were delivered 
via telephone; in the current study, the items regarding the time of the veteran’s last CRC 
screening test were modified so that participants could respond to these open-ended 
questions via paper survey.  Although CRC screening adherence was gathered from the 
participants’ medical record, some participants received CRC screening outside of the 
VAMC system and medical record data confirming that procedure were not always 
available.  Thus, participants were asked whether they underwent FOBT or FIT in the 
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past year, flexible sigmoidoscopy in the past 5 years, or colonoscopy in the past 10 years 
and the location of these tests, if applicable.  In the case of discrepancy between the 
medical record and self-report, the medical record data were used to determine screening 
status.  Often, the medical record clearly identified CRC screening adherence as 
evidenced by either receipt of the screening test at the VAMC or by scanned medical 
records from an outside facility.  However, if patients had reported adherence to CRC 
screening at an outside facility to their PCP (i.e., noted by the PCP in the medical record), 
but this was not supported by outside records which had been entered into the medical 
record and they reported non-adherence to CRC screening on the study survey, patients 
were coded as non-adherent.  Given the research questions posed, individuals who were 
adherent to both stool blood test and endoscopy at the time of consent were coded as 
adherent to endoscopy.  
 Trust in PCP. Five items assessed the patient’s trust in his PCP (Dugan et al., 
2005).  In the original measure development study, participants responded to items over 
the phone such as “sometimes Dr._ [INSERT NAME OF DR.]__ cares more about what 
is convenient for (him/her) than about your medical needs,” which were individualized 
with the participants’ doctor’s name (Dugan et al., 2005).  Test-retest reliability of the 
measure over two months was 0.71 and Cronbach’s alpha was 0.87 (Dugan et al., 2005).  
In the current study, participants were asked to think about their PCP while responding to 
items such as “sometimes your doctor cares more about what is convenient for him or her 
than about your medical needs.”  Responses were measured on a 5-point, Likert-type 
scale with responses ranging from 1 (strongly disagree) to 5 (strongly agree) (Dugan et 
al., 2005).  In the current study, the internal consistency reliability of this scale was .870.   
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Conformity to Masculine Norms Inventory-46. The Conformity to Masculine 
Norms Inventory-46 (CMNI-46) (Parent & Moradi, 2009) is a 46-item, shortened version 
of the original 94-item Conformity to Masculine Norms Inventory (Mahalik et al., 2003).  
Forty-six items assessed the following masculinity norms: Risk-taking, Winning, 
Violence, Emotional Control, Self-reliance, Power Over Women, Playboy, Primacy of 
Work, and Heterosexual Self-Presentation (Parent & Moradi, 2009).  Internal consistency 
reliability of the 46-item measure was adequate in the original measure development 
study (α = 0.82) (Parent & Moradi, 2011).  In addition, correlations between the 
subscales of the original Conformity to Masculine Norms Inventory and those of the 46-
item version ranged from 0.89 to 0.98 (Mahalik et al., 2003; Parent & Moradi, 2009).  
Responses were measured using a four-point Likert-type scale ranging from 0 (strongly 
disagree) to 3 (strongly agree).   
Three subscales of the measure (i.e., heterosexual self-presentation, risk-taking, 
and self-reliance) were examined in this study.  The following items were reverse-scored: 
5, 6, 10, 17, and 38 (Parent & Moradi, 2009; Parent & Moradi, 2011).  Items 5, 14, 17, 
24, 37, and 46 were summed and the average was taken to determine the heterosexual 
self-presentation subscale score (Parent & Moradi, 2009; Parent & Moradi, 2011).  In the 
current study, internal consistency reliability of this subscale was .852. For the risk-
taking subscale score, items 6, 8, 16, 28, and 35 were summed and the average was 
determined (Parent & Moradi, 2009; Parent & Moradi, 2011).  Internal consistency 
reliability of this subscale was .698 in the present study.  Finally, items 3, 10, 26, 38, and  
  
 
32 
43 were summed and averaged to calculate the self-reliance subscale score (Parent & 
Moradi, 2009; Parent & Moradi, 2011). In the current study, internal consistency 
reliability of this subscale was .746. 
 Cancer-related Fear. Cancer-related fear was measured using eight items modified 
from the Breast Cancer Fear Scale developed by Champion and colleagues (2004).  In the 
original study, eight items were retained (e.g., “when I think about breast cancer, I feel 
anxious”); in the current study, the specifier of “breast” cancer was deleted so that the 
eight items would reflect general cancer fear (e.g., “when I think about cancer, I feel 
anxious”) (Champion et al., 2004).  Reliability of the Breast Cancer Fear Scale has been 
established; Cronbach’s alpha was shown to be α = 0.91 and two to three month test-
retest reliability was demonstrated to be 0.70 (Champion et al., 2004).  Responses were 
measured using a five-point, Likert-type scale, ranging from 1 (strongly disagree) to 5 
(strongly agree) (Champion et al., 2004).  The mean of the summed score was used in 
analyses.  Internal consistency reliability of this scale was .922 in the present study. 
 
Statistical Analyses 
Data Cleaning and Reduction. All data were analyzed using SPSS (Version 22, 
Copyright © 2013 IBM SPSS Statistics, Chicago, IL, USA).  First, the amount of missing 
data was determined (Schafer & Graham, 2002).  Next, it was determined whether data 
were missing at random or if there was a pattern in nonresponse (Schafer & Graham, 
2002).  Using Little’s MCAR test, it was determined that data were not missing 
completely at random.  A variety of methods for handling missing data were considered 
including casewise deletion, listwise deletion, maximum likelihood (ML), and single and 
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multiple imputation (MI).  Ultimately, series mean imputation was chosen because in the 
case of all but the income variable, less than 5% of any data were missing.  The 
dissertation proposal stated that single imputation would be used in the case of variables 
missing less than 5%, multiple imputation would be used in the case of variables missing 
more than 5%, and NORM software would be utilized to impute five data sets.  However, 
it was found that only one variable, income, had missing data greater than this amount 
(6.7% missingness) and that the NORM software was out-of-date.  Given the low amount 
of missing data, series mean imputation was instead utilized, and values were randomly 
assigned (Rand, personal communication, September 22, 2014).  All study scale scores 
and the length of the patient-provider relationship were calculated prior to conducting the 
primary analyses.  The length of the patient-provider relationship was calculated by 
subtracting the date of the participant’s first visit to his PCP (as reported in the electronic 
medical record) from the date of consent.  In addition, physician recommendation for 
CRC screening was calculated such that individuals responding “yes” to any of the three 
questionnaire items assessing whether they had received a recommendation for stool 
blood test, sigmoidoscopy, or colonoscopy from their doctor were coded as having 
received a physician recommendation.  Individuals at increased risk for CRC and those 
who consented, but failed to complete more than 60% of the study questionnaire, were 
excluded from analyses.  
Preliminary analyses (i.e., descriptive statistics, scatterplots, histographs, residual 
score analysis) were conducted to examine the data for normality, linearity, kurtosis, 
homoscedasticity, and outliers.  Outliers were examined as potential data entry errors.  
Descriptive statistics were computed to characterize the participants’ demographic 
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characteristics, health experiences, trust in PCP, cancer fear, masculinity subscale scores, 
and CRC screening adherence.  Correlations between study variables were also 
computed.  Ultimately, data from 327 individuals were analyzed.   
Analyses for Aim #1. Analyses for Aim #1 examined the extent to which three 
aspects of masculinity (i.e., heterosexual self-presentation, risk-taking, and self-reliance) 
were associated with CRC screening adherence (i.e., stool blood test [FOBT or FIT] in 
the past year or endoscopy [sigmoidoscopy in the past 5 years or colonoscopy in the past 
10 years]) while controlling for age, race, and education level.  It was hypothesized that 
three aspects of masculinity (i.e., heterosexual self-presentation, risk-taking, and self-
reliance) would be inversely associated with CRC screening adherence (i.e., stool blood 
test [FOBT or FIT] in the past year or endoscopy [sigmoidoscopy in the past 5 years or 
colonoscopy in the past 10 years]) (see Aim #1, Hypothesis #1.1).  To test this 
hypothesis, three separate logistic regression analyses were conducted to examine the 
relationship between the masculinity variables (i.e., heterosexual self-presentation, risk-
taking, and self-reliance) and CRC screening adherence (coded “yes” or “no”) while 
controlling for age, race, and education level.  
Analyses for Aims #2 and #3. Using the Hayes (2012, 2013) PROCESS macro, 
analyses were conducted to examine whether: 1) the relationship between risk-taking and 
CRC screening adherence was partially mediated by cancer fear (Aim #2, Hypothesis 
#2.1) while controlling for age, race, and education level; 2) the relationship between 
self-reliance and CRC screening adherence was partially mediated by trust in PCP (Aim 
#2, Hypothesis #2.2) while controlling for age, race, and education level; 3) age 
moderated the strength of the relationship between cancer fear and CRC screening 
  
 
35 
adherence such that the relationship between cancer fear and CRC screening was weaker 
with increasing age (Aim #3, Hypothesis #3.1) while controlling for race and education 
level; 4) race moderated the strength of the relationship between trust in PCP and CRC 
screening adherence such that the relationship between trust in PCP and CRC screening 
was stronger among African-Americans compared to Whites (Aim #3, Hypothesis #3.2) 
while controlling for age and education level; and 5) length of patient-provider 
relationship moderated the strength of the relationship between trust in PCP and CRC 
screening adherence such that the relationship between trust in PCP and CRC screening 
was stronger with increasing length of patient-provider relationship (Aim #3, Hypothesis 
#3.3) while controlling for age, race, and education level.      
Both Preacher and Hayes’s method of moderated mediation and structural 
equation modeling were considered for analyses (Hayes, 2009).  After careful 
consideration, it was decided that Preacher and Hayes’s method of moderated mediation 
would be used in this study (Hayes, 2009).  With moderated mediation, a researcher is 
able to examine whether a variable (X) affects an outcome (Y) indirectly through a 
mediator, and if that indirect effect is stronger among certain groups of participants (a 
moderator) (Hayes, 2009, 2013).  Use of the Hayes (2012, 2013) PROCESS macro 
allowed for a direct test of the proposed pathways and relationships among variables.  If 
structural equation modeling analyses had been used, it would have required a multiple 
group comparison of models without allowing for a direct test of the proposed pathways 
and relationships (Hayes, 2009, 2013).   
The PROCESS macro combines Hayes’s prior macros (i.e., MODMED, 
MODPROBE, SOBEL, INDIRECT, and MEDTHREE/MED3C) and allows for more 
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complex analyses than did previously available macros (Hayes, 2012, 2013).  Using 
bootstrapping, the PROCESS macro examines indirect effects of moderated mediation 
through logistic regression or ordinary least squares regression analyses (Hayes, 2012, 
2013).  Bootstrapping allowed for the examination of the indirect effects of masculinity 
beliefs on CRC screening adherence through health beliefs such as cancer fear and trust 
in PCP through resampling from the data set five thousand times (Preacher & Hayes, 
2004; Preacher & Hayes, 2008; Shrout & Bolger, 2002).  Advantages of the 
bootstrapping method include the lack of assumption of normality and enhanced power to 
detect indirect effects relative to older statistical methods (Preacher & Hayes, 2004; 
Preacher & Hayes, 2008; Shrout & Bolger, 2002).  The bootstrapping method was used 
to estimate a 95% confidence interval; if the confidence interval did not include zero, the 
indirect effect was considered statistically significant (Preacher & Hayes, 2004; Preacher 
& Hayes, 2008; Shrout & Bolger, 2002).  
Demographic covariates were included in all models.  Specifically, because 
higher education has been associated with performance of CRC screening in prior 
research (Beydoun & Beydoun, 2008; Cokkinides, Chao, Smith, Vernon, & Thun, 2003; 
Halbert et al., 2011), education (i.e., HS diploma, GED, or less education vs. some 
college or more education) was included as a covariate in all models.  In addition, older 
age has been associated with receipt of CRC screening (Beydoun & Beydoun, 2008; 
Cokkinides et al., 2003; Tessaro et al., 2006).  Thus, age was a covariate in all models, 
with the exception of Aim #3, Hypothesis #3.1, which included age as a moderator.  
Furthermore, because White race has been associated with a higher likelihood of CRC 
screening in prior research (Beydoun & Beydoun, 2008), race  (i.e., White vs. minority 
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race) was a covariate in all models with the exception of Aim #3, Hypothesis #3.2, which 
included race (i.e., White vs. Black or African-American race) as a moderator.   
Because the PROCESS macro uses bias-corrected bootstrapping to correct for 
data with a non-normal distribution (Hayes, 2012, 2013), the work of Fritz and 
MacKinnon (2009) was consulted in order to determine the appropriate sample size to 
obtain 80% power.  It would have been ideal to have an estimate of effect size in order to 
determine the necessary sample size for this study (Fritz & MacKinnon, 2007); however, 
because no prior study has examined the relationship between masculinity and CRC 
screening adherence, the effect size for the study was unknown.  According to Fritz and 
MacKinnon (2009), for a study involving bias-corrected bootstrapping, a sample size 
between 34 (for large α and β effect sizes) and 462 (for small α and β effect sizes) is 
required.  It was hypothesized that the effect sizes for α and β in the proposed study 
would likely be small or medium.  Thus, with 350 participants, a moderate effect size 
(Cohen’s d = 0.39) or 13% of the variance in the model may have been able to be 
detected with 80% power depending upon the effect sizes of the α and β paths (Fritz & 
MacKinnon, 2007).  
Analyses for Aim #4. Aim #4, Hypothesis #4.1 stated that aspects of masculinity 
(i.e., heterosexual self-presentation, risk-taking, and self-reliance) would predict CRC 
screening adherence above and beyond the predictive value of race, age, education, 
physician recommending CRC screening, and family/friend recommending CRC 
screening.  To test this hypothesis, logistic regression analyses were conducted with race, 
education, age, physician recommendation for CRC screening, and family or friend 
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recommendation for CRC screening entered on the first step of the equation and the three 
masculinity variables entered on the second step.  
 Analyses for Aim #5. The fifth aim was to examine associations between three 
aspects of masculinity (i.e., heterosexual self-presentation, risk-taking, and self-reliance) 
and CRC screening status (i.e., non-adherence, adherence with stool blood test [FOBT or 
FIT in the past year], or adherence with endoscopy [sigmoidoscopy in the past 5 years or 
colonoscopy in the past 10 years]) in male VA primary care patients aged 51-75 while 
controlling for age, race, and education level.  To address this aim, a multinomial logistic 
regression analysis was used to examine the extent to which three aspects of masculinity 
predicted stool blood test screening (relative to non-adherence) and endoscopic screening 
(relative to non-adherence) while controlling for age, race, and education level. 
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RESULTS 
 
Study Flow 
 A total of 561 male veterans with a scheduled PCP visit were approached 
regarding the study.  One hundred and fifty-six veterans declined to participate either 
prior to (n = 151) or following eligibility screening (n = 5).  Reasons for refusal include 
lack of interest, concern that participation would be too much work, health reasons, prior 
negative experiences with CRC screening, privacy concerns, enrollment or considering 
enrollment in another CRC study, and lack of time, among others (see Figure 1).  Of note, 
five of the individuals who declined participation also mentioned being unable to 
complete paperwork or read.  However, these 5 responses were considered refusals 
because the veterans were not adequately screened for eligibility (i.e., the ability to read 
and write).  An additional 55 individuals were found to be ineligible during the screening 
or consent process.  Reasons for ineligibility were based upon responses to the screening 
questionnaire (n = 24) and information gathered during the consent process (n = 31; e.g., 
demonstration of cognitive impairment, verbal report of ineligibility criteria).  Interested 
and eligible veterans (N = 350) consented to participate in the study.  Study flow and 
reasons for refusal and ineligibility are found in Figure 1.
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Participant Characteristics 
Of the 350 consenting individuals, 233 (67%) were adherent to current CRC 
screening guidelines and 117 were non-adherent.  Twenty-three individuals either did not 
return their study questionnaires or returned questionnaires which had extensive missing 
data; thus, data from 327 participants were included in the current analyses.  Of these, 
213 individuals (65%) were adherent to CRC screening guidelines at the time of consent.  
Of the adherent participants, 196 individuals were adherent through the following tests: 
1) colonoscopy alone, 2) both colonoscopy and sigmoidoscopy, or 3) both colonoscopy 
and stool blood testing.  The other 17 adherent participants were adherent to stool blood 
testing alone.  The remaining 114 individuals were non-adherent to CRC screening 
guidelines at the time of consent. 
Sample characteristics are displayed in Table 2.  The average age of study 
participants was 62 years (SD = 5.8).  The majority of participants self-identified as 
White or Caucasian (73%), and 21% identified as Black or African American.  Fifty-five 
percent were married and 64% had completed at least one semester of college.  Most 
participants were unemployed or retired (69%), and more than half lacked health 
insurance other than VA benefits (59%) and reported a household income of less than 
$31,000 (59%).  According to medical records, about half of participants had a female 
PCP (50.2%), and the average length of time that participants had seen their PCP was 48 
months (SD = 46.57).  Of note, 8.6% of participants did not have an identified PCP 
recorded in the medical record.  The majority of participants (91%) reported that they had  
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received a recommendation from their physician to receive CRC screening, and 55% of 
participants reported that their family members or friends had recommended that they 
complete CRC screening.   
 
Correlations Between Study Variables 
Intercorrelations between study variables are displayed in Table 3.  Briefly, 
correlational analyses showed that older age was associated with increased likelihood of 
CRC screening adherence (p < 0.001).  Furthermore, White race was correlated with 
older age (p = 0.023), increased risk-taking (p = 0.008), and lower levels of heterosexual 
self-presentation (p = 0.020).  Greater education was correlated with lower levels of 
heterosexual self-presentation and cancer fear (p = 0.002 and p = 0.044, respectively) as 
well as increased risk-taking and CRC screening adherence (p = 0.014 and p = 0.022, 
respectively).  In addition, risk-taking was negatively correlated with heterosexual self-
presentation (p = 0.015) and positively correlated with self-reliance (p = 0.019).  Self-
reliance also was positively associated with cancer fear (p = 0.015) and negatively 
associated with trust in one’s PCP (p = 0.004).  Having received a family member or 
friend recommendation for CRC screening was correlated with reduced trust in PCP (p = 
0.005, greater cancer fear (p = 0.019), and receipt of a PCP recommendation for CRC 
screening (p = 0.031).  Receiving a recommendation for CRC screening from a PCP or 
family member or friend was associated with increased likelihood of CRC screening 
adherence (p < .001 and p = 0.034, respectively).  No additional significant relationships 
were found between study variables. 
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Aim 1 Results 
Examine the extent to which three aspects of masculinity (i.e., heterosexual self-
presentation, risk-taking, and self-reliance) are associated with CRC screening 
adherence (i.e., stool blood test [FOBT or FIT] in the past year or endoscopy [i.e., 
sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years]) in male VA 
primary care patients aged 51-75 while controlling for age, race, and education level..  
Hypothesis 1.1 posited that three aspects of masculinity (i.e., heterosexual self-
presentation, risk-taking, and self-reliance) would be inversely associated with CRC 
screening adherence (i.e., stool blood test [FOBT or FIT] in the past year or endoscopy 
[sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years]) while controlling 
for age, race, and education level.  To test this hypothesis, each of the masculinity 
variables was examined as a predictor of CRC screening adherence in separate logistic 
regression analyses.  As shown in Figures 2-4, none of the masculinity variables were 
significant predictors of screening status while controlling for age, education level, and 
race.  In each of the three models, increasing age and lower levels of education were 
predictive of receiving CRC screening according to guidelines, whereas race did not 
predict this outcome (see Table 4).   
 
Aim 2 Results 
Examine potential mediators of the relationship between aspects of masculinity (i.e., risk-
taking and self-reliance) and CRC screening adherence (i.e., stool blood test [FOBT or  
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FIT] in the past year or endoscopy [sigmoidoscopy in the past 5 years or colonoscopy in 
the past 10 years]) in male VA primary care patients aged 51-75 while controlling for 
age, race, and education level.     
Hypothesis 2.1 postulated that cancer fear would partially mediate the relationship 
between risk-taking and CRC screening adherence (i.e., stool blood test [FOBT or FIT] in 
the past year or endoscopy [sigmoidoscopy in the past 5 years or colonoscopy in the past 
10 years]) while controlling for age, race, and education level.  To test this hypothesis, 
the indirect effect of risk-taking on CRC screening adherence through cancer fear was 
calculated using the bootstrapping method in the PROCESS macro (indirect effect = 
0.0053, SE = 0.0238, p  = 0.7892, 95% CI = -0.0202 to 0.0904; see Tables 5 and 6).  As 
shown in Figure 5, cancer fear did not mediate the relationship between risk-taking and 
CRC screening adherence.  There were no significant paths in the model.   
Regarding Hypothesis 2.2, it was expected that trust in PCP would partially 
mediate the relationship between self-reliance and CRC screening adherence (i.e., stool 
blood test [FOBT or FIT] in the past year or endoscopy [sigmoidoscopy in the past 5 
years or colonoscopy in the past 10 years]) while controlling for age, race, and education 
level.  To test this hypothesis, the indirect effect of self-reliance on CRC screening 
adherence through trust in PCP was calculated using the bootstrapping method in the 
PROCESS macro (indirect effect = 0.0091, SE = 0.0480,  p  = 0.8388, 95% CI = -0.0791 
to 0.1205; see Tables 5 and 7).  As shown in Figure 6, trust in PCP did not mediate the 
relationship between self-reliance and CRC screening adherence.  The only significant 
path in this model was a negative relationship between self-reliance and trust in PCP (B = 
-0.3104, p = 0.005, 95% CI = -0.5241 to -0.0967).  
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Aim 3 Results 
Examine potential moderators of relationships specified in the models proposed in Aim 
#2 while controlling for demographic covariates.  
 Hypothesis 3.1 posited that age would moderate the strength of the relationship 
between cancer fear and CRC screening adherence such that the relationship would be 
weaker with increasing age while controlling for race and education level.  To test this 
hypothesis, a conditional process model was examined using the PROCESS macro.  As 
shown in Figure 7, results indicated that age did not moderate the relationship between 
cancer fear and CRC screening adherence (index of moderation mediation = 0.0024, SE = 
0.0061, 95% CI = -0.0050 to 0.0232; see Tables 8 and 9).  There were no significant 
paths in the model.   
Regarding Hypothesis 3.2, it was suggested that race would moderate the strength 
of the relationship between trust in PCP and CRC screening adherence such that the 
relationship would be stronger among African Americans compared to Whites while 
controlling for age and education level.  The PROCESS macro was again used to test this 
conditional process model.  As shown in Figure 8, race did not moderate the relationship 
between trust in PCP and CRC screening adherence (index of moderation mediation = -
0.0241, SE = 0.1268, 95% CI = -0.3176 to 0.2058; see Tables 8 and 10).  The only 
significant path in the model was a negative relationship between self-reliance and trust 
in PCP (B = -0.3143, SE = 0.1078, p = 0.0038, 95% CI = -0.5264 to -0.1023).   
Hypothesis 3.3 posited that length of patient-provider relationship would 
moderate the strength of the relationship between trust in PCP and CRC screening 
adherence such that the relationship would be stronger with increasing length of patient-
  
 
45 
provider relationship while controlling for age, race, and education level.  As shown in 
Figure 9, results of analyses using the PROCESS macro indicated that length of patient-
provider relationship did not moderate the relationship between trust in PCP and CRC 
screening adherence (index of moderation mediation = -0.0005, SE = 0.0013, 95% CI = -
0.0036 to 0.0018; see Tables 8 and 11).  The only significant path in the model was a 
negative relationship between self-reliance and trust in PCP (B = -0.3104, SE = 0.1086, p 
= 0.0046, 95% CI = -0.5241 to -0.0967).     
 
Aim 4 Results 
Examine the extent to which three aspects of masculinity (i.e., heterosexual self-
presentation, risk-taking, and self-reliance) are associated with CRC screening behavior, 
controlling for the effects of variables recognized as significant predictors of CRC 
screening in prior research (i.e., White race, older age, higher education level, physician 
recommending CRC screening, family and friends recommending CRC screening).     
Hypothesis 4.1 suggested that three aspects of masculinity (i.e., heterosexual self-
presentation, risk-taking, and self-reliance) would predict CRC screening adherence 
above and beyond the predictive value of race, age, education, physician recommending 
CRC screening, and family/friend recommending CRC screening.  To test this 
hypothesis, a hierarchical logistic regression analysis was conducted with four variables 
entered on the first step (i.e., race, age, education, physician recommending CRC 
screening, and family/friend recommending CRC screening) and the three masculinity 
variables entered on the second step.  Results did not support Hypothesis 4.1 (see Table 
12).  Furthermore, physician recommendation for CRC screening and age were the only 
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significant predictors of CRC screening adherence in the model.  Specifically, lack of 
physician recommendation for CRC screening (B = -2.677, p < 0.001, 95% CI = 0.022 to 
0.212) and increasing age (B = 0.084, p < 0.001, 95% CI = 0.382 to 1.096) were 
associated with CRC screening adherence. 
 
Aim 5 Results 
Examine associations between three aspects of masculinity (i.e., heterosexual self-
presentation, risk-taking, and self-reliance) and CRC screening status (i.e., non-
adherence, adherence with stool blood test [FOBT or FIT in the past year], or adherence 
with endoscopy [sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years]) 
in male VA primary care patients aged 51-75 while controlling for age, race, and 
education level. 
 A multinomial logistic regression analysis was conducted to address this 
exploratory aim.  As shown in Table 13, none of the masculinity variables (i.e., 
heterosexual self-presentation, risk-taking, and self-reliance) were predictive of CRC 
screening adherence.  When examining adherence to endoscopy, older age (B = 0.082, p 
< 0.001, 95% CI = 1.040 to 1.134) and higher levels of education were significant 
predictors of this outcome (B = 0.565, p = 0.028, 95% CI = 1.064 to 2.908), whereas, 
when examining adherence to a stool blood test, none of the examined variables were 
predictive of this outcome.  Of note, SPSS produced an error message when completing 
this analysis which was likely related to the small number of participants adherent to  
  
 
47 
CRC screening guidelines with stool blood test only (n = 17) (Rand, personal 
communication, September 19, 2014).  Thus, caution when interpreting the results of this 
analysis is warranted.  
Given the small number of participants adherent to CRC screening guidelines 
with stool blood test only, an additional logistic regression analysis was conducted after 
omitting data from these individuals.  This analysis examined the extent to which three 
aspects of masculinity (i.e., heterosexual self-presentation, risk-taking, and self-reliance) 
predicted adherence to endoscopy while controlling for age, race, and education level.  In 
this model, none of the masculinity variables were predictive of endoscopy status.  
Instead, this status was only associated with age (B = 0.086, p < 0.001, 95% CI = 1.042-
1.138) and education level (B = -0.580, p = 0.024, 95% CI = 0.339-0.926) (see Table 14).  
Specifically, increasing age and lower levels of education were associated with 
completion of CRC screening with endoscopic tests.   
To summarize the relations of covariates to CRC screening adherence across 
analyses, age and race showed consistent relationships with this outcome, whereas 
education did not.  Specifically, older age was associated with increased likelihood of 
CRC screening adherence and race was uncorrelated with this outcome across all 
analyses.  Higher levels of education were only related to increased CRC screening 
adherence in bivariate correlational analyses and the multinomial logistic regression 
analysis which created the error message.  Conversely, in the majority of regression 
analyses, lower levels of education were related to increased likelihood of CRC screening 
adherence.
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DISCUSSION 
 
 
Summary of Study Results 
Colorectal cancer is the third most common cause of cancer deaths and yet, CRC 
screening rates are suboptimal among men in the United States (American Cancer 
Society, 2014a; American Cancer Society, 2014b).  With improved understanding of 
barriers to CRC screening adherence, interventions can be designed to address these 
barriers, increase CRC screening rates, and decrease mortality from CRC.  In the present 
study, masculinity beliefs were examined as potential barriers to men’s CRC screening 
adherence because qualitative studies have provided suggestive evidence of this 
relationship (Bass et al., 2011; Beeker et al., 2000; Getrich et al., 2012; Goldman et al., 
2009; Harvey & Alston, 2011; Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, et 
al., 2010; Rivera-Ramos & Buki, 2011; Thompson et al., 2011; Wackerbarth et al., 2005; 
Winterich et al., 2009).  
The primary aim of this study was to test the hypothesis that the masculinity 
variables of heterosexual self-presentation, self-reliance, and risk-taking would be 
inversely associated with CRC screening adherence.  These three masculinity variables 
were chosen because prior qualitative research and masculinity theory suggest the 
following: 1) masculine men should present themselves as heterosexual and, by 
extension, distain cancer screening involving the rectum (e.g., colonoscopy) which could 
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affect their perceptions of their sexuality (Brannon, 1976; Getrich et al., 2012; Harvey & 
Alston, 2011; Holt et al., 2009; Jones, Devers, et al., 2010; Thompson et al., 2011; 
Winterich et al., 2011); 2) men with higher levels of risk-taking beliefs may not perceive 
disease such as CRC to be a threat to their well-being and, thus, may not engage in 
preventive behaviors such as CRC screening (Bem, 1974; Courtenay, 2000a, 2000b, 
2011; Millar & Houska, 2007; Nicholas, 2000); and 3) men who endorse self-reliance 
ideals may not consistently receive health care, which limits their opportunity to receive a 
recommendation for CRC screening (Boman & Walker, 2010; Hammond, Matthews, & 
Corbie-Smith, 2010; Iwamoto et al., 2011; Locke & Mahalik, 2005; Mahalik et al., 2006; 
Mahalik et al., 2003; Pachankis et al., 2011; Pleck et al., 1993; Wade, 2009).  
Contrary to the primary study hypothesis, none of these masculinity variables 
were significantly associated with CRC screening adherence in bivariate correlational or 
logistic regression analyses controlling for established predictors of the outcome.  
Specifically, these three aspects of masculinity failed to predict CRC screening adherence 
above and beyond the predictive value of race, age, education, physician 
recommendation, and family/friend recommendation.  However, results suggested that 
lack of physician recommendation for CRC screening and increasing age were associated 
with a higher likelihood of CRC screening adherence. 
A multinomial logistic regression analysis also was used to examine the extent to 
which the three aspects of masculinity predicted stool blood test screening (relative to 
non-adherence) and endoscopic screening (relative to non-adherence) while controlling 
for age, race, and education level.  However, only 17 individuals in the sample were 
adherent to CRC with stool blood test alone, and the statistical software produced an 
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error message.  Due to the small number of participants adherent to CRC screening 
guidelines with stool blood test alone, a final logistic regression analysis was conducted 
after omitting data from these individuals.  This analysis examined the extent to which 
the three masculinity variables predicted endoscopic screening relative to non-adherence.  
Results showed that none of the masculinity variables predicted endoscopic screening. 
In addition, analyses were conducted to test mediational and moderated 
mediational models of the relationships between two aspects of masculinity (i.e., risk-
taking and self-reliance) and CRC screening adherence.  The following models were 
hypothesized: 1) cancer fear would partially mediate the relationship between risk-taking 
and CRC screening adherence; 2) trust in PCP would partially mediate the relationship 
between self-reliance and CRC screening adherence; 3) age would moderate the strength 
of the relationship between cancer fear and CRC screening adherence; 4) race would 
moderate the strength of the relationship between trust in PCP and CRC screening 
adherence; and 5) length of patient-provider relationship would moderate the strength of 
the relationship between trust in PCP and CRC screening adherence.  Mediation and 
moderated mediation analyses did not support any of the five hypothesized models; 
however, a significant negative relationship was found between self-reliance and trust in 
PCP.   
Regarding study covariates, increasing age was associated with a higher 
likelihood of CRC screening adherence, and race was unrelated to this outcome across all 
analyses.  In addition, level of education (i.e., whether one had a history of college 
attendance) was inconsistently associated with adherence to CRC screening.  In multiple 
regression analyses, lower levels of education was a significant predictor of CRC 
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screening adherence.  However, in one of the regression analyses (i.e., the multinomial 
logistic regression analysis which produced an error message), mediation and moderated 
mediation analyses, and the bivariate correlational analysis, higher levels of education 
were associated with CRC screening adherence.  In yet another regression analysis, level 
of education was not a significant predictor of CRC screening adherence.  Potential 
explanations for study findings are provided below. 
 
Fit with Existing Literature 
Results of qualitative studies suggest that masculinity beliefs may be related to 
men’s willingness to undergo endoscopic CRC screening (Bass et al., 2011; Beeker et al., 
2000; Getrich et al., 2012; Goldman et al., 2009; Harvey & Alston, 2011; Holt et al., 
2009; Jilcott Pitts et al., 2013; Jones, Devers, et al., 2010; Rivera-Ramos & Buki, 2011; 
Thompson et al., 2011; Wackerbarth et al., 2005; Winterich et al., 2009).  To the author’s 
knowledge, prior quantitative studies have not examined associations between 
masculinity beliefs and CRC screening.  The present findings suggest that three 
masculinity beliefs (i.e., heterosexual self-presentation, risk-taking, and self-reliance) 
may not in fact be associated with CRC screening adherence.  However, previous 
research suggests that two of these facets of masculinity (i.e., heterosexual self-
presentation and self-reliance) are related to other health behaviors in men (Hammond, 
Matthews, Mohottige et al., 2010; Mahalik, Levi-Minzi, & Walker, 2007; Levant, 
Wimer, & Williams, 2011; Parent, Torrey, & Michaels, 2012).  For example, 
heterosexual self-presentation was negatively associated with HIV testing among men 
who have sex with men (Parent, Torrey, & Michaels, 2012).  In addition, in a study of 
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adult men aged 18-78, the masculinity subscales of self-reliance, violence, and playboy 
predicted health risk behaviors (e.g., unhealthy lifestyle choices and substance use), 
whereas other masculinity subscales (e.g., risk-taking, heterosexual self-presentation) did 
not predict these behaviors (Mahalik, Levi-Minzi, & Walker, 2007; Levant, Wimer, & 
Williams, 2011).  Another study of self-reliance in men produced counterintuitive 
findings; greater self-reliance was associated with more prompt receipt of cholesterol 
screening (Hammond, Matthews, Mohottige et al., 2010).  In addition, self-reliance was 
unrelated to the receipt of blood pressure screening or a routine medical check-up 
(Hammond, Matthews, Mohottige et al., 2010).  Thus, given the limited research to date, 
a clear pattern of associations between the masculinity ideals of self-reliance and 
heterosexual self-presentation and health behaviors has not emerged. 
Although theory suggests that adherence to the masculinity ideal of risk-taking 
might lead to decreased worry about health and less engagement in healthy behaviors 
(Brannon, 1976; Courtenay, 2011; Nicholas, 2000; Parent & Moradi, 2009; Walker, 
Tokar, & Fischer, 2000), risk-taking has not been found to be associated with preventive 
health behaviors in men (Hammond, Matthews, Mohottige et al., 2010; Mahalik, Levi-
Minzi, & Walker, 2007; Levant, Wimer, & Williams, 2011; Parent, Torrey, & Michaels, 
2012).  Thus, findings of the current study are consistent with prior empirical literature, 
but do not support masculinity theory (Brannon, 1976; Courtenay, 2000a, 2000b, 2011).  
It is important to note that the risk-taking ideal has been measured with items such as “I 
take risks” and “I frequently put myself in risky situations” (Parent & Moradi, 2009).  
Thus, a willingness to take risks rather than beliefs about vulunerability to health risks is 
the construct under examination in the current study and prior research.  Developing 
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masculinity measures which assess perceived risk and vulnerability to disease or poor 
health would allow further testing of masculinity theory.  Further research is also needed 
to assess whether the masculinity ideal of risk-taking is more strongly associated with 
risky health behaviors than a lack of preventive health behaviors among men.  Indeed, in 
one study of men, adherence to the risk-taking ideal was associated with drinking alcohol 
to intoxication (Iwamoto et al., 2011).  
It is also possible that masculinity ideals not considered in the current study, such 
as the primacy of work and pursuit of status, may be associated with CRC screening 
behaviors.  To date, studies have found variable associations between a range of 
masculinity ideals and health behaviors in men.  For example, in one study, the 
masculinity ideals of primacy of work and dominance were positively associated with 
preventive health behaviors (i.e., testicular self-exam, skin cancer self-exam, and an 
annual physical exam), whereas the pursuit of status was negatively associated with these 
behaviors (Levant, Wimer, and Williams, 2011).  However, other masculinity ideals (e.g., 
self-reliance, disdain for homosexuality, violence) were not associated with these health 
behaviors (Levant, Wimer, and Williams, 2011).  The authors also found variable 
associations between aspects of masculinity and health risk behaviors, which led them to 
conclude the following:  
the relationship between health behavior and masculine gender socialization 
varies according to specific dimension of health behavior and the specific 
masculine gender socialization construct.  It seems from these data and prior 
research that some facets of masculinity are associated with health protective 
factors, whereas others are associated with health risk factors (Levant, Wimer, 
and Williams, 2011, pg. 26).  
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Thus, the relationship between aspects of masculinity and health behaviors in men is 
quite complex such that further theory development and multi-faceted assessment of 
constructs are needed.  Unfortunately, many studies use a total masculinity score rather 
than subscale scores, which limits theoretical progress and comparisons between the 
current study and prior studies (Boman & Walker, 2010; Mahalik & Burns, 2011; 
Mahalik, Burns, & Syzdek, 2007; Springer & Mouzon, 2011).   
Potential mediators of relationships between masculinity variables and CRC 
screening adherence also were examined in this study.  Contrary to hypotheses, cancer 
fear did not partially mediate the relationship between risk-taking and CRC screening 
adherence.  Masculinity theory suggests that men who hold risk-taking beliefs may not 
feel that CRC or other diseases are a threat to their well-being (Courtenay, 2000a, 2000b, 
2011; Nicholas, 2000).  In addition, due to beliefs regarding the importance of 
suppressing emotions, it may be that men adhering to risk-taking and other masculinity 
ideals are not willing to endorse emotions such as fear (Brannon, 1976; Millar & Houska, 
2007; Parent & Moradi, 2009; Walker, Tokar, & Fischer, 2000).   
To the author’s knowledge, the relationship between the masculinity ideal of risk-
taking and cancer fear has not been previously examined among men.  Regarding the 
relationship between fear and cancer screening, prior studies have revealed mixed results, 
largely depending upon whether general cancer fear, fear of a specific cancer type (e.g., 
breast cancer fear), or trait fear was examined (Consedine, 2012; Consedine et al., 2004; 
Consedine et al, 2006; Hay, Buckley, & Ostroff, 2005; Kleier, 2010).  Additionally, many 
studies of cancer fear have featured female participants (Consedine et al., 2004; Hay, 
Buckley, & Ostroff, 2005) and, to the author’s knowledge, none have examined CRC 
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screening.  Although general cancer fear has been positively associated with other types 
of cancer screening (Consedine et al., 2004), it was not associated with CRC screening 
adherence in this study.  It is possible that these variables are not related, or that CRC-
specific fear may be more closely related to CRC screening behavior.   
The null mediation finding with respect to cancer fear has several potential 
explanations.  First, it is possible that other variables (e.g., cancer fatalism, comfort with 
receipt of CRC screening test procedures or lack of embarrassment, perceptions of 
normative health behaviors, and negative attitudes toward accessing healthcare) may 
better account for the relationship between risk-taking and CRC screening status than 
cancer fear (Consedine, Ladwig, Reddig, & Broadbent, 2011; Consedine, Reddig, 
Ladwig, & Broadbent, 2011; Levant et al., 2013; Mahalik, Burns, & Syzdek, 2007; 
Shelton et al., 2011).  These potential mediators were not assessed in the current study 
and deserve consideration for future research.  In addition, the analyses may have lacked 
statistical power to detect mediation due to lower numbers of non-adherent individuals in 
the sample.   
Also contrary to hypotheses, age did not moderate the strength of the relationship 
between cancer fear and CRC screening adherence.  It was hypothesized that cancer fear 
would be a weak predictor of CRC screening among older participants based on prior 
research with cancer survivors in which fear of death and fear of cancer recurrence 
showed inverse associations with age (Cicirelli, 2006; Crist & Grunfeld, 2013; Lebel, 
Beattie, Arès, & Bielajew, 2013; Ziner et al., 2012).  To the author’s knowledge, age has 
not been examined as a moderator of relationships between fear and any type of cancer 
screening in prior research.  However, in a recent study, greater fear of a CRC diagnosis 
  
 
56 
predicted non-receipt of CRC screening among older, but not younger adults in Spain 
(e.g., age 50-59 vs. 60 and over) (Molina-Barceló, Salas-Trejo, Peiró-Perez, Vanaclocha, 
Pérez, & Castán, 2014).  Thus, the extent to which age moderates the relationship 
between cancer fear and cancer screening deserves further study.  Although not 
considered as moderators in prior literature, it is also possible that other variables may 
moderate the relationship between cancer fear and CRC screening (e.g., perceived risk of 
CRC, family history of CRC screening, prior physician recommendation for CRC 
screening, self-efficacy for test completion) (Beydoun & Beydoun, 2008; Brouse et al., 
2008; Centers for Disease Control and Prevention, 2012b; Farmer et al., 2008; Friedman 
et al., 2004; Guessous et al., 2010; Halbert et al., 2011; Honda, 2004; Jandorf et al., 2010; 
Kremers et al., 2000; Myers et al., 1994; Post et al., 2008; Tabbarah et al., 2005; Tessaro 
et al., 2006).  Given variability in the relationship between fear and cancer screening, 
exploring potential moderators of this relationship is an important direction for future 
research (Consedine, 2012; Consedine et al., 2004; Consedine et al, 2006; Hay, Buckley, 
& Ostroff, 2005; Kleier, 2010). 
This study also examined whether trust in PCP accounted for the relationship 
between the masculinity ideal of self-reliance and CRC screening adherence.  
Masculinity theory suggests that men who endorse self-reliance ideals may avoid 
healthcare services and therefore may not have the opportunity to develop a relationship 
of trust with a healthcare provider and receive a recommendation for CRC screening 
(Boman & Walker, 2010; Hammond, Matthews, & Corbie-Smith, 2010; Iwamoto et al., 
2011; Locke & Mahalik, 2005; Mahalik et al., 2006; Mahalik et al., 2003; Pachankis et 
al., 2011; Pleck et al., 1993; Wade, 2009).  Indeed, a negative relationship between self-
  
 
57 
reliance and trust in one’s PCP was found in the current study, suggesting that men who 
believe that “real men” should be self-reliant may be less likely to trust a healthcare 
provider.  However, in the current study, trust in PCP was not associated with CRC 
screening adherence, which contrasts with prior findings among low-income, non-veteran 
patients (Greiner et al., 2005).  Also, contrary to hypotheses, trust in PCP did not partially 
mediate the relationship between self-reliance and CRC screening adherence.  These null 
findings may have been due, in part, to a restriction of range in the trust in PCP variable 
with most participants endorsing a high level of trust in their provider.  As the study took 
place immediately prior to a primary clinic appointment, it is possible that participants 
did not feel comfortable revealing low levels of trust in their provider.  In addition, 
veterans who were seeing a provider for the first time on the date of consent may have 
been reporting their level of trust in the healthcare system in general or a previous 
provider, which may have influenced study results.  Additionally, other variables 
associated with CRC screening adherence in prior literature such as comfort with 
receiving a physical examination (e.g., lack of embarrassment) or self-efficacy for test 
completion may better explain the relationship between self-reliance and CRC screening 
adherence (Consedine, Ladwig, Reddig, & Broadbent, 2011; Consedine, Reddig, Ladwig, 
& Broadbent, 2011; Halbert et al., 2011; Kremers et al., 2000; Myers et al., 1994; Tessaro 
et al., 2006).  Furthermore, it is possible that trust in PCP was mediating the relationship 
between self-reliance and CRC screening adherence, but the analyses may have lacked 
statistical power to detect mediation due to lower numbers of non-adherent individuals in 
the study.   
  
 
58 
Contrary to hypotheses, race did not moderate the strength of the relationship 
between trust in PCP and CRC screening adherence.  It was hypothesized that race might 
affect the relationship between trust in PCP and CRC screening; specifically, it was 
expected that the relationship between trust in PCP and CRC screening would be stronger 
among African Americans compared to Whites.  Especially among ethnic minority 
populations, lack of trust in the healthcare system has been indicated as a barrier to 
receiving preventive health services (Fyffe, Hudson, Fagan, & Brown, 2008; Greiner, 
Born, Nollen, & Ahluwalia, 2005; Hammond, Matthews, Mohottige, Agyemang, & 
Corbie-Smith, 2010; Jones, Devers, et al., 2010).  However, this study and prior research 
have not supported this hypothesis.  For example, in one study, race (African American 
vs. White) and trust in PCP did not significantly interact to predict receipt of prostate-
specific antigen tests (Musa et al., 2009).  In the current study, several factors may have 
reduced statistical power for testing moderation, including the relatively small sample of 
African Americans and range restriction with respect to the trust in PCP variable.  In 
addition, other variables not previously considered as moderators may affect the 
relationship between trust in PCP and CRC screening adherence (e.g., patient-provider 
racial concordance, patient-provider gender concordance) (Bonds, Foley, Dugan, Hall, & 
Extrom, 2004; Menees, Inadomi, Korsnes & Elta, 2005; Saha, Komaromy, Koepsell, & 
Bindman, 1999) and deserve exploration in future research.   
Also contrary to hypotheses, length of patient-provider relationship did not 
moderate the strength of the relationship between trust in PCP and CRC screening 
adherence.  Based upon patient trust theory which suggests that interpersonal trust in 
one’s PCP is developed through multiple interactions with a PCP and evaluation of the 
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PCP’s behavior throughout these interactions (Pearson & Raeke, 2000), it was 
hypothesized that the relationship between trust in PCP and CRC screening would be 
stronger with increasing length of patient-provider relationship.  To the author’s 
knowledge, length of patient-provider relationship had not been previously examined as a 
moderator of the relationship between trust in PCP and health behaviors in any 
population.  The current study findings suggest that length of patient-provider 
relationship may not moderate the relationship between trust in PCP and CRC screening.  
However, null findings may have been due to a restriction of range in the trust in PCP 
variable as well as the length of patient-provider relationship variable.  For example, a 
physician who carried a large patient panel left the PCP clinic soon after the current study 
began.  Thus, many patients had only recently begun seeing their current provider.  
Specifically, 50 participants were scheduled for their initial PCP visit at the time of 
consent.  In addition, 28 participants did not have a current PCP assigned at the time of 
consent.  All of these contextual factors might have affected the relationships among 
study variables. 
Relationships between study covariates (i.e., age, education level, and race) and 
CRC screening adherence also were examined.  As has been demonstrated in prior 
literature (Beydoun & Beydoun, 2008; Cokkinides et al., 2003; Tessaro et al., 2006), 
increasing age was associated with a greater likelihood of being adherent to CRC 
screening guidelines.  Older individuals may have had more opportunities to receive CRC 
screening and may have had increased awareness of their risk for CRC.  Contrary to prior 
literature (Beydoun & Beydoun, 2008; Cokkinides, Chao, Smith, Vernon, & Thun, 2003; 
Halbert et al., 2011), lower levels of education were associated with a higher likelihood 
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of CRC screening adherence in the majority of regression analyses.  However, higher 
levels of education were associated with an increased likelihood of CRC screening in 
bivariate analyses and the mediation and moderated-mediation models.  Of note, the use 
of the bootstrapping method as well as the inclusion of other variables in the models may 
have contributed to a change in the direction of the association between education level 
and CRC screening adherence across mediation analyses.  In addition, race was not a 
significant predictor of CRC screening adherence in regression analyses or bivariate 
analyses.  If the current study had included veterans accessing healthcare services as well 
as those not currently accessing healthcare services, race may have been more predictive 
of CRC screening adherence.  Among veterans, race and CRC screening adherence have 
shown differential associations across studies (Burgess et al., 2011; Dolan et al., 2005).  
For example, in a mail-based study of African American and White veterans from 24 
different VA Medical Centers, White race was associated with CRC screening adherence 
prior to controlling for other demographic and cognitive variables (Burgess et al., 2011).  
Conversely, in a study of veterans accessing services in a VA primary care clinic, African 
Americans were more likely to adhere to CRC screening guidelines than Whites (Dolan 
et al., 2005).  Interestingly, in the former study, CRC screening adherence rates were 
higher among Whites who were married and well-educated and higher among African 
Americans who were unmarried and had lower levels of education (Burgess et al., 2011).  
Thus, the examination of demographic subgroups (e.g., interactions between race and 
marital status) may be informative in future research which features larger samples of 
ethnic minority individuals. 
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Furthermore, the relationships between CRC screening adherence and physician 
recommendation and family or friend recommendation for CRC screening were 
examined, as these variables have been associated with CRC screening adherence in 
previous studies (Gilbert & Kanarek, 2005; Taylor et al., 2003).  Consistent with prior 
literature (Gilbert & Kanarek, 2005; Taylor et al., 2003), bivariate analyses suggested a 
positive association between CRC screening adherence and physician recommendation 
for CRC screening.  However, physician recommendation was negatively associated with 
CRC screening adherence in one set of regression analyses.  These findings may be have 
been due to the use of the bootstrapping method and the presence of other variables in the 
model.  Family and friend recommendation for CRC screening showed a significant, 
positive association with CRC screening adherence in bivariate analyses, but was not a 
significant predictor in the regression analyses.  In prior research, family or friend 
encouragement for receiving CRC screening has been associated with greater odds of 
being at a higher stage of adoption for both FOBT and colonoscopy (Wang et al., 2014).  
In addition, greater perceived family member or friend support for CRC screening 
predicted CRC screening adherence in men and women attending Appalachian churches 
(Tessaro et al., 2006).  However, in a study conducted among low-income and 
predominantly African-American individuals who were non-adherent to CRC screening 
guidelines at the time of receiving a CRC screening intervention, there was no significant 
relationship between family member or friend recommendation for CRC screening and 
CRC screening behavior (Brouse et al., 2008).  Social factors (e.g., marital status, number 
and quality of friendships) might help explain variability in relationships between 
family/friend CRC screening recommendation and screening behaviors.  Of note, in the 
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current study, a lower percentage of men were married compared to the general 
population of men of their age (U.S. Census Bureau, 2012), and being married has been a 
significant predictor of CRC screening in prior literature (Guessous et al., 2010).  Future 
studies might consider the closeness of the relationship as well as the type of relationship 
(e.g., spouse, child, friend, sibling) between the patient and the person who has 
recommended CRC screening when predicting CRC screening adherence.  
 
Potential Explanations for Study Results 
Several sample characteristics may have contributed to null study results.  First, 
study participants were veterans accessing primary care services within a VA hospital.  
Veterans represent a unique sector of the United States population in that those with an 
honorable discharge from the military are eligible for low-cost or free healthcare services 
at VA Medical Centers (Morgan, Teal, Reddy, Ford, & Ashton, 2005).  Compared to the 
general population of adults in the U.S. and veterans who do not access healthcare 
through the VA system, veterans accessing care at VA Medical Centers are less likely to 
be employed and are more likely to be older, to self-identify as African American, to 
have lower levels of income and education, and to have more medical and mental health 
diagnoses (Morgan et al., 2005).  Furthermore, veterans accessing healthcare services 
may differ from those unwilling to see a PCP with respect to masculinity beliefs and 
other characteristics.  If the present study had been conducted among individuals who 
were not currently accessing healthcare services or those who had not seen a PCP for 
preventive care in the past several years, results may have revealed different relationships 
between study variables (e.g., masculinity beliefs, trust in PCP, and CRC screening 
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adherence).  In addition, there was a restriction of range in responses to two of the three 
masculinity subscales, as few men had masculinity scores at the upper end of the scale.  
For example, the mean score on the self-reliance scale was 1.24 and the highest mean 
score was 2.40, although the scale maximum is 3.0.  Similarly, the mean score on the 
risk-taking scale was 1.10, with few individuals reporting the maximum score of 3.0.  Of 
note, the sample consisted of middle-age and older men (i.e., 51-75 years), and 
masculinity beliefs have been found to decline with increasing age (Terracciano, McCrae, 
& Costa, 2006).  Declining masculinity beliefs with increasing age may be due to poorer 
health and greater dependency on health care and other services to fulfill one’s needs.  
Finally, it is possible that study refusals or missing data may have been related to literacy 
and/or health literacy issues; however, literacy and health literacy were not assessed 
during the study. 
Study findings may also be related to several VA system-level factors.  First, in 
recent years, there has been a system-wide emphasis on increasing CRC screening 
adherence rates among veterans (Chao et al., 2009; Jackson et al., 2010).  A successful 
national initiative to improve CRC screening rates at VA Medical Centers in the last 
several years included electronic medical record reminders as well as performance 
incentives for physicians (Chao et al., 2009).  These efforts may have led to increased 
patient awareness of CRC screening which may have impacted screening rates, making it 
more difficult to recruit non-adherent individuals.  Lower numbers of non-adherent 
veterans in this study may have reduced statistical power for detecting effects.  
Furthermore, men who continue to be non-adherent in the VA healthcare system may 
differ on important characteristics from non-adherent men who do not access VA 
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services.  Another VA system-level factor that may have influenced study results was 
recruitment for a large, national randomized controlled trial comparing the efficacy of the 
FIT test to colonoscopy in the same primary care clinics as the current study.  The 
ongoing recruitment for that study may have influenced our consent rates and study 
results.  Specifically, some veterans may have confused the nature of the current study 
(i.e., study questionnaire only) versus the randomized controlled trial (i.e., intervention 
with CRC testing), which may have reduced the consent rate.  It is also possible that, 
among veterans who were non-adherent to CRC screening, those who declined the 
current study held different beliefs about CRC screening or other study variables than 
those who agreed to participate.  A third system-level factor potentially influencing study 
results is that many individuals had experienced a recent change in their PCP.  Some 
participants had recently begun to receive care at the VA, whereas others had recently 
switched providers within the hospital.  During the study, one long-time PCP with a large 
patient panel left the main clinic where recruitment took place, and his patients were 
either without a listed PCP or had been recently transferred to other providers whom they 
may or may not have met previously.  Indeed, for 50 participants, the date of consent was 
their first visit to the provider, and 28 participants were not yet assigned to a regular PCP 
at the time of consent.  Thus, a change in providers may have contributed to null findings 
in this study, such as the lack of relationship between trust in one’s PCP and CRC 
screening adherence.   
Furthermore, study design issues may have influenced study results.  First, the 
research assistants for the study were both female.  The gender of the research assistants 
may have led to lower levels of consent among some men as well as socially desirable 
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responses from study participants.  Prior research has demonstrated that the gender of 
research assistants conducting study interviews may influence participant responses 
(Davis, Couper, Janz, Caldwell, & Resnicow, 2010).  Specifically, in prior research about 
gender roles and characteristics (e.g., masculinity and femininity), response biases that 
were “more socially progressive responses or responses that deferred to the interviewer's 
gender” were revealed among participants of both genders responding to male versus 
female interviewers (Davis, Couper, Janz, Caldwell, & Resnicow, 2010, p. 22).  For 
example, one telephone survey found that male participants who were more highly 
educated and reported being low in power in their romantic relationship endorsed more 
liberal gender role views to a female research assistant than those interviewed by a male 
research assistant (Lueptow, Moser, & Pendleton, 1990).  It is unclear whether or how the 
gender of research assistants in the current study may have influenced responses to the 
masculinity variables.  Although the questionnaire was self-administered, the informed 
consent process was conducted in-person, and participants gave their paper questionnaire 
directly to the female research assistant.  One veteran who refused to participate in the 
study mentioned his discomfort with discussing the topic of CRC screening with a female 
research assistant.   
In addition, despite the confidential nature of the study, participants may not have 
felt comfortable providing honest responses to the masculinity questions which broached 
potentially sensitive topics (e.g., beliefs about power over women and heterosexual self-
presentation).  Multiple participants wrote comments such as “I’m not gay” in the 
margins of the survey near the heterosexual self-presentation masculinity subscale items 
demonstrating awareness (and perhaps concern) that their responses would be reviewed.  
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Second, the study was conducted in the primary care clinic just prior to the patient’s visit 
with his provider, which may have resulted in response biases.  As noted previously, 
there was a restriction of range in the trust in PCP variable, with the majority of 
individuals indicating high levels of trust in their healthcare provider.  Third, in addition 
to using medical record review, the current study relied upon self-report measures of 
CRC screening adherence, which may have contributed to reponse biases and 
inaccuracies.  There were 56 instances of incongruence between the medical record and 
self-reported CRC screening status.  Specifically, 46 participants reported that they were 
up-to-date with CRC screening which was not supported by medical record 
documentation, and 10 participants reported that they were non-adherent which was not 
supported by medical record documentation. 
Measurement issues may have also influenced study results.  First, the current 
masculinity scale was not initially validated in samples of older adults or veterans.  
Instead, the masculinity scale had been normed with male college students (Parent & 
Moradi, 2009; Parent & Moradi, 2011; Parent, Moradi, Rummell, & Tokar, 2011) who 
may respond differently to items as compared to older male veterans.  However, the 
questionnaire has subsequently been administered to both undergraduate and community-
dwelling men aged 18 to 63 (Levant & Wimer, 2014a), men aged 22 to 78 who have sex 
with men (Parent, Torrey & Michaels, 2012), and men and women aged 18 to 83 (Parent 
& Smiler, 2013).  To the author’s knowledge, the present study represents the first time 
that the masculinity scale was administered to veterans.  In addition, the masculinity 
scales assessed general masculinity beliefs without referring to masculinity in relation to 
a healthcare context.  For example, the scales do not assess masculinity beliefs related to 
  
 
67 
screening tests or medical services which breach physical boundaries.  These beliefs may 
be more proximal to CRC screening behavior.  For example, if the current study had 
utilized an item such as “a colonoscopy can affect masculinity” (modified from an item 
designed by Paiva et al., 2011), a significant relationship between CRC screening 
adherence and this belief may have been found.  Taken together, characteristics of the 
measures, sample, VA system, and study design may have affected the response rate, 
accuracy of study data, and ability to attain statistical significance. 
 
Limitations 
Limitations of this study should be noted.  First, the study features a cross-
sectional design and, thus, causal relationships and changes in beliefs and behaviors over 
time could not be examined.  Indeed, it may be that study variables such as masculinity 
beliefs and CRC screening adherence would be correlated longitudinally, although they 
were not related in this cross-sectional study.  Second, veterans who agreed to participate 
in this study may have differed in important ways from those who declined participation, 
especially with respect to CRC screening adherence.  These differences may have 
contributed to less variability in responses to study questionnaires.  However, the 
percentage willing to undergo eligibility screening (73% of those approached) was 
comparable to that of prior research on veterans’ CRC screening adherence.  For 
example, a cross-sectional survey on CRC screening among non-adherent veterans 
conducted in clinic yielded a 74% participation rate (Dolan et al., 2004).  Another study 
of CRC screening conducted via mailed survey yielded a slightly higher participation rate 
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of 81% with differential response rates between African American and White VA 
patients (i.e., 73% for African American veterans and 89% for White veterans).   
Third, variables which may be related to masculinity ideals, such as willingness to 
access healthcare services, perceptions of normative health behaviors, perceived barriers 
to accessing healthcare, self-efficacy, and gender role stress were not included in study 
analyses (Levant & Wimer, 2014b; Mahalik, Burns, & Syzdek, 2007).  Indeed, a recent 
study demonstrated that general self-efficacy and perceptions of normative health 
behaviors partially mediated the relationships between masculinity ideals (i.e., the 
CMNI-46 total score which includes 9 masculinity beliefs) and health behaviors (i.e., 
Health Behavior Inventory-20 total score which includes a range of health-promoting and 
health-risk behaviors) (Levant & Wimer, 2014b; Levant, Wimer, & Williams, 2011).  
Fourth, the study relied upon self-report measures.  It is possible that participants 
provided inaccurate responses due to social desirability, poor literacy, or, more 
specifically, poor health literacy; however, CRC screening tests were described in 
layperson’s terms on the study questionnaire.  Fifth, participants’ medical comorbidities 
were not assessed, as the relationship between comorbidities and CRC screening has been 
inconsistent (Fleming et al., 2011; Lukin et al., 2012).  However, comorbidity coupled 
with increasing age may affect whether a patient receives a CRC screening 
recommendation as well as the test modality (i.e., FOBT or FIT vs. colonoscopy) 
recommended by his PCP (Haggstrom, Klabunde, Smith, & Yuan, 2013).  In addition, of 
note, a lower percentage of men in the current study reported being married compared to 
men in the United States population of similar age (e.g., 55% in the current study vs. 70-
78% for United States men age 45-74) (U.S. Census Bureau, 2012).  The relationship 
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between marital status and CRC screening adherence was not examined in the current 
study.  However, in multiple prior studies, being married has generally been associated 
with CRC screening adherence, but has not consistently predicted this outcome 
(Guessous et al., 2010; Patel et al., 2013; Shires et al., 2011; van Jaarsveld, Miles, 
Edwards, & Wardle, 2006; Weiss et al., 2013).   
Sixth, general cancer fear rather than CRC-specific fear was assessed.  
Furthermore, fear of CRC screening methods was not measured, which has been 
predictive of screening behavior in prior studies (Jibara, Jandorf, Fodera, DuHamel, 
2011; Lee, Consedine, & Spencer, 2011).  Finally, the majority of the sample self-
identified as White, and the sample was limited to male veterans who were engaged in 
PCP services and receiving their care at a single Midwestern VAMC, which limits 
generalizability to dissimilar populations.  Veterans represent a unique population of 
individuals who, depending upon their circumstances, have access to PCP and CRC 
screening services at little or no cost.  Thus, findings may not generalize to non-veterans, 
men who do not have a regular PCP or readily available access to CRC screening 
services, women, and those from racial minority groups.   
 
Future Research Directions and Recommendations 
Based on the study findings, a number of future research directions warrant 
consideration.  First, in order to test masculinity theory in a healthcare context, measures 
assessing masculinity beliefs as they relate to the receipt of healthcare services, including 
CRC screening, should be developed (e.g., items such as “a real man does not allow a 
doctor to exam his body” or “a real man does not let a doctor insert objects into his 
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rectum as part of a medical test”).  As noted previously, the current masculinity measure 
assessed general beliefs that may be less predictive of CRC screening adherence or 
medical care use compared to more specific masculinity beliefs related to healthcare.   
Second, longitudinal studies are needed to assess potential changes in masculinity 
beliefs as men age and their relationship to the use of healthcare services in VA and non-
VA settings.  In a longitudinal study of personality, scores on the masculinity scale of the 
Guilford-Zimmerman Temperament Survey were found to decline with increasing age in 
a linear fashion over a 42 year period among both men and women (Terracciano, 
McCrae, & Costa, 2006); however, this study was not conducted with veterans and 
correlates of this decline were not assessed.  Masculinity beliefs theoretically associated 
with healthcare receipt (i.e., self-reliance, heterosexual self-presentation, risk-taking) may 
be expected to change as men access more health services.  For example, as men place 
greater trust in their providers based upon more frequent interactions with them, a sense 
of self-reliance may decline.   
In addition, the hypotheses of the current study should be tested in different 
populations.  For example, the study should be conducted with a more ethnically diverse 
sample, as participants in the current study were generally White or African American.  
Future studies should recruit participants from other ethnic groups to assess whether 
between-group differences in relationships between masculinity beliefs and CRC 
screening adherence exist.  In qualitiative studies, many of the men reporting concerns 
about the maintenance of masculinity in the context of invasive cancer testing were from 
minority groups (e.g., African American and Latino or Hispanic men) (Bass et al., 2011; 
Beeker et al., 2000; Getrich et al., 2012; Harvey & Alston, 2011; Holt et al., 2009; 
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Rivera-Ramos & Buki, 2011; Thompson et al., 2011; Winterich et al., 2009).  Thus, 
research studies should examine masculinity beliefs and related cultural beliefs that may 
impact CRC screening adherence and other health behaviors in specific minority groups.  
In addition, this research should be extended to non-veterans and men who do not 
regularly use primary care services, as their masculinity beliefs and CRC screening 
adherence may differ from those of veterans who regularly use primary care services.  
Finally, further research is necessary to explore a range of theory-driven mediators and 
moderators of relationships between masculinity beliefs and CRC screening.  
 
Conclusions 
Qualitative studies have suggested that some men believe that medical tests 
involving the rectum may be an affront to commonly-held masculinity ideals.  The 
current quantitative study aimed to examine the relationship between the masculinity 
beliefs of risk-taking, self-reliance, and heterosexual self-presentation and colorectal 
cancer screening behaviors among male veterans accessing primary care services.  These 
masculinity variables were not significantly associated with CRC screening adherence in 
correlational and logistic regression analyses.   
Results of the present study lead to a number of research questions to be 
examined in future research.  Relationships between study variables should be examined 
in a population not actively accessing healthcare services.  In addition, as mentioned, 
these research questions should be examined among specific minority groups (e.g., 
African-American and Latino men) to better understand relationships between study 
variables and cultural beliefs which may be associated with healthcare beliefs, 
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masculinity ideals, and health behaviors.  Furthermore, future studies should include non-
veteran samples, as their masculinity ideals and healthcare use beliefs and behaviors may 
differ from those of veterans.  In addition, future studies should develop and utilize 
masculinity measures which assess beliefs more proximal to receiving CRC screening 
and other healthcare.  Finally, prospective and longitudinal research studies are needed to 
better understand relationships among study variables.  
If masculinity beliefs are found to be related to CRC screening adherence in 
future studies, gender-specific CRC screening interventions could be developed that 
address values important to men in order to foster CRC screening adherence 
(Friedemann-Sanchez et al., 2007).  For example, men could receive tailored messages 
which encourage CRC screening in order to maintain masculinity norms that are 
important to them (e.g., maintain one’s health in order to support one’s family) (O'Brien, 
Hunt, & Hart, 2005).  In addition, study findings could be applied to research regarding 
other preventive health behaviors among men.  
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Table 1. Quotations from qualitative studies reflecting masculinity norms and cancer 
screening involving the rectum  
Quotation: Participant 
characteristics if 
known: 
Source: 
…probing around in my rectum . . . [is] treading 
on my masculinity.  
African-
American man 
under age of 65 
Beeker et al., 
2000, p. 268 
I think there’s an aspect that people think it’s gay 
and there’s that whole sexual issue about it. If 
you’re willingly to submit to doing this thing, you 
could never tell anyone about it. . .So I am 
wondering if it’s part of this homosexual thing or 
this fear of having a digital rectal exam or having 
someone messing around your butt. Maybe I have 
some questions about my own sexuality, my own 
sexual orientation. What do I do if I like it? What 
if I find out something about myself while I’m 
having this exam? Or what if I have questions 
about myself, what if I’m insecure and that’s what 
keeps me from going to have this exam. How do 
you address that insecurity if it’s sexual identity 
or sexual orientation?   
African-
American man 
Harvey & 
Alston, 2011, p. 
147 
Demeaning…[because] that’s where you’re most 
vulnerable.  
Caucasian man Winterich et al., 
2011, p. 531 
The myth about that type of procedure— 
they always relate it to a sexual encounter. You 
do 
not want nobody to fool around your butt because 
they might think they are bisexual. 
African-
American man 
Holt et al., 2009, 
p. 881 
…you know, guys are usually reluctant to have 
colonoscopies because I guess it is a male ego 
thing you know, having something inserted into 
your rectum. 
African-
American man 
Bass et al., 2011, 
p. 124 
…like a taboo. [People] don’t want the doctor to 
insert the finger. That’s what a lot of people have 
on their minds. 
Mexican-
American man 
Getrich et al., 
2012, p. 8 
…compromised position…(where)…you’re 
pretty much at the mercy of somebody. 
Caucasian man Winterich et al., 
2011, p. 531 
…biggest fear…someone placing something in 
my rectum, that’s how most men are. 
African-
American man 
Winterich et al., 
2009, p. 6 
You might want to call me old school…certain 
part of the body wasn’t made for entrance in a 
man [laughs].  
African-
American man 
Winterich et al., 
2011, p. 531 
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Table 1, continued. 
If you were a man, you didn’t do that….Hey, you 
don’t get any hand put up your butt. 
African-
American man 
Harvey & 
Alston, 2011, p. 
147 
But the other thing is women are better than men, 
I’m afraid, at dealing with these things. Men are 
um (.) I was going to say phobic, if you like. I 
was going to take it one step further and [say] … 
homophobic, if you like, because, you know, 
you’re talking about men’s bottoms and that sort 
of thing. Do you know what I mean?  
Man from New 
Zealand 
Thompson et al., 
2011, p. 9-10 
 
It is not so much the worry. It is the intrusion 
part…It is just in my make up. It is an intrusion to 
keep having to go in a man’s rectum. 
African-
American man 
Bass et al., 2011, 
p. 124 
I think it’s problematic for men…especially 
homophobic men…they think you let someone do 
that to you, you ain’t a real man. 
Man from 
Virginia, USA 
Jones, Devers, et 
al., 2010, p. 512 
I’m sorry, I don’t mean to interrupt, but let's get 
real. The myths about a lot of black males are that 
to protect that macho image, you don’t have 
anybody messing around with your butt. 
African-
American man 
Harvey & 
Alston, 2011, p. 
147 
[My friend] told me he had lost his manhood. So, 
we must be very careful with that because people 
think that they lose their manhood 
Latino man Rivera-Ramos & 
Buki, 2011, p. 20 
[Men's] attitudes [toward the DRE] are not the 
best… because sometimes they do things that 
[physically] hurt more [than the DRE]. But, the 
fact is that it is an uncomfortable experience 
because they do it in a [body] part where it is not 
usual for a man to [get examined]. And yes, as 
liberal as I may be, I still do not like to be touched 
in that [body] part; even if it's once a year. 
Latino man Rivera-Ramos & 
Buki, 2011, p. 20 
Just part of the body guys feel uncomfortable 
about. 
Caucasian man Winterich et al., 
2009, p. 5 
Men don’t like for anyone to touch them there. 
The same goes for me. That’s why I hadn’t gone 
over there [in Mexico]. I spent lots of effort 
[there] protecting [my sexuality] just to give it up 
in the United States [laughs].  
Man from 
Mexico living in 
the United States 
Getrich et al., 
2012, p. 8 
 
An insult to my manhood….(And the reason that 
you don’t like the finger test is because of the 
invasiveness?) Invasiveness, and maybe just call 
me homophobic. I don’t play that. I’m the 
screwer, not the screwee. 
African-
American 
Winterich et al., 
2009, p.7 
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Table 1, continued. 
Violated…men don’t like for people going up 
in…the rectum… I’m a man, and I just don’t feel, 
I don’t feel comfortable like that! 
African-
American man 
Winterich et al., 
2009, p. 5 
Something’s up in your rectum would be kind of 
a compromised position for me. 
Caucasian man Winterich et al., 
2009, p. 6 
Certain parts of the body weren’t made for 
entrance in a man. 
African-
American man 
Winterich et al., 
2009, p. 6 
I think probably a lot of them feel the same way I 
do about it, it’s not very comfortable, kind of 
embarrassing….(And why do you think they feel 
that way?)…I just think it’s the way that men are 
probably brought up, and, you know, raised up as 
to…be exposed to another man like that in that 
kind of setting. 
Caucasian man Winterich et al., 
2009, p. 7 
I hate it. It’s one of the most dangerous tests a 
doctor can give me. For him. (For him?) Yeah. 
Because it depends upon my mental state how I 
am going to respond to that test. Hopefully my 
mental state is analytical, scientific, and within 
control. I don’t want it to be in my normal 
reaction of protection. Because I may be old but 
even old rattlesnakes can kill you (laughs). 
African-
American man 
Winterich et al., 
2009, p. 8 
It’s kind of always hard for macho guys, you 
know, shoving this thing up your butt, is not 
something that everyone really looks forward to. 
Man from USA Wackerbarth et 
al., 2005, p. 547 
Most guys . . . the reason they don’t have it 
[screening] is because first they’s gonna think 
about somebody is going to be violating them and 
going up their rectum. 
Man from USA Pitts et al., 2013, 
p. 84 
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Table 2. Sample characteristics (N = 327) 
Demographic variable Descriptive statistics 
 M (SD), Range 
Age 61.9 (5.8), 51-75 
Length of relationship with PCP (in months) 48.5 (46.57), 0-199 
 % (n) 
Race                  White 
                          Black or African-American 
                          Asian-American/Pacific Islander 
                          Native American 
                          Hispanic/Latino 
                          Other/More than one race 
  73 (238) 
21 (68) 
               <1 (2) 
2 (7) 
               <1 (1) 
  3 (11) 
Education 
                          HS diploma/GED or less                      
                          Some college or greater 
 
36 (119) 
64 (208) 
Employment status  
                          Unemployed/Retired 
                          Employed 
 
69 (226) 
31 (101) 
Income 
                         $30,999 or less 
                         $31,000 or greater 
 
59 (194) 
41 (133) 
Marital status 
                         Single, separated, divorced 
                         Married 
                         Widowed 
 
40 (131) 
55 (179) 
5 (17) 
Health insurance status 
                         Yes 
                         No 
 
41 (135) 
59 (192) 
Gender of PCP 
                          Male 
                          Female 
                          Missing 
 
41.3 (135) 
50.2 (164) 
8.6 (28) 
Physician recommendation for CRC screening 
                          Yes 
                          No 
 
91 (297) 
9 (30) 
Family/friend recommendation for CRC screening 
                          Yes 
                          No 
 
55 (181) 
45 (146) 
Note: HS = high school; GED = General Education Development; PCP = primary care 
provider; CRC = colorectal cancer
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Table 6. Cancer fear as mediator of the relationship between risk-taking and colorectal 
cancer screening adherence (Aim #2, Hypothesis #2.1) 
 
Note: N = 327  
 
The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes. 
 
Significant results are displayed in bold. 
 
Coefficients are unstandardized. 
 
SE = standard error; CI = confidence interval; CRC = colorectal cancer. 
Outcome: Cancer fear 
Variable Coefficient SE t p-value 95% CI 
Constant  3.3545 0.5615  5.9740 <0.01   2.2498-4.4593 
Risk-taking -0.0698 0.1172 -0.5960  0.5516 -0.3004-0.1607 
Age -0.0068 0.0089 -0.7628  0.4461 -0.0242-0.0107 
Race1  0.0462 0.1170  0.3952  0.6930 -0.1839-0.2763 
Education level2 -0.2007 0.1073 -1.8698  0.0624 -0.4119-0.0105 
Outcome: CRC screening adherence 
Variable Coefficient SE z p-value 95% CI 
Constant -4.7038 1.4227 -3.3063 0.0009 -7.4922--1.9154 
Cancer fear -0.0762 0.1304 -0.5843 0.5590 -0.3317-0.1794 
Risk-taking -0.0655 0.2764 -0.2369 0.8128 -0.6071-0.4762 
Age  0.0821 0.0216  3.7994 0.0001  0.0397-0.1244 
Race1  0.3540 0.2683  1.3194 0.1870 -0.1719-0.8799 
Education level2  0.5112 0.2491  2.0526 0.0401  0.0231-0.9994 
Outcome: CRC screening adherence 
Total effect model 
Variable Coefficient SE z p-value 95% CI 
Constant -4.9512 1.3590 -3.6433 0.0003 -7.6148--2.2877 
Risk-taking -0.0608 0.2761 -0.2204 0.8256 -0.6019-0.4802 
Age  0.0825 0.0216  3.8225 0.0001  0.0402-0.1247 
Race1  0.3509 0.2679  1.3098 0.1903 -0.1742-0.8760 
Education level2  0.5254 0.2478  2.1199 0.0340  0.0396-1.0111 
 
 Effect SE z p-value 95% CI 
Total effect of  
X on Y 
-0.0608 0.2761 -0.2204 0.8256 -0.6019-0.4802 
Direct effect of  
X on Y 
-0.0655 0.2764 -0.2369 0.8128 -0.6071-0.4762 
Indirect effect of  
X on Y 
  0.0053 0.0199  0.2674 0.7892  
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Table 6, continued. 
1Race coded as 0 = minority race and 1 = White race. 
2Education level coded as 0 = HS diploma or GED or less and 1 = some college or more. 
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Table 7. Trust in PCP as mediator of relationship between self-reliance and colorectal 
cancer screening adherence (Aim #2, Hypothesis #2.2) 
 
Outcome: Trust in PCP 
Variable Coefficient SE t p-value 95% CI 
Constant  4.7655 0.5644  8.4433 <0.01  3.6551-5.8759 
Self-reliance -0.3104 0.1086 -2.8573  0.0046 -0.5241--0.0967 
Age -0.0036 0.0087 -0.4138  0.6793 -0.0208-0.0136 
Race1 -0.0372 0.1143 -0.3254  0.7451 -0.2620-0.1876 
Education level2  0.0064 0.1045  0.0617  0.9509 -0.1991-0.2120 
Outcome: CRC screening adherence 
Variable Coefficient SE z p-value 95% CI 
Constant -4.3325 1.5311 -2.8297  0.0047 -7.3334--1.3317 
Trust in PCP -0.0292 0.1353 -0.2160  0.8290 -0.2943-0.2359 
Self-reliance -0.3919 0.2655 -1.4762  0.1399 -0.9123-0.1284 
Age  0.0810 0.0217  3.7295  0.0002  0.0384-0.1235 
Race1  0.3936 0.2681  1.4680  0.1421 -0.1319-0.9190 
Education level2  0.5103 0.2465  2.0706  0.0384  0.0273-0.9933 
Outcome: CRC screening adherence 
Total effect model 
Variable Coefficient SE z p-value 95% CI 
Constant -4.4760 1.3809 -3.2414  0.0012 -7.1826--1.7695 
Self-reliance -0.3834 0.2624 -1.4613  0.1439 -0.8976-0.1308 
Age  0.0811 0.0217  3.7404  0.0002  0.0386-0.1237 
Race1  0.3939 0.2681  1.4692  0.1418 -0.1316-0.9193 
Education level2  0.5106 0.2464  2.0722  0.0382  0.0277-0.9936 
 
 Effect SE z p-value 95% CI 
Total effect of  
X on Y 
-0.3834 0.2624 -1.4613  0.1439 -0.8976-0.1308 
Direct effect of  
X on Y 
-0.3919 0.2655 -1.4762  0.1399 -0.9123-0.1284 
Indirect effect of  
X on Y 
 0.0091 0.0446  0.2043  0.8388  
Note: N = 327 
 
The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes. 
 
Significant results are displayed in bold. 
 
Coefficients are unstandardized. 
 
SE = standard error; PCP = primary care provider; CI = confidence interval; CRC = 
colorectal cancer 
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Table 7, continued. 
1Race coded as 0 = minority race and 1 = White race. 
2Education level coded as 0 = HS diploma or GED or less and 1 = some college or more. 
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Table 9. Moderated mediation of relationship between risk-taking and colorectal cancer 
screening adherence (Aim #3, Hypothesis #3.1) 
Outcome: Cancer fear 
Variable Coefficient SE t p-value 95% CI 
Constant 2.9439 0.1596 18.4459 <0.01 2.6299-3.2579 
Risk-taking -0.0670 0.1170 -0.5722 0.5676 -0.2972-0.1633 
Race1 0.0348 0.1159 0.3000 0.7644 -0.1933-0.2628 
Education level2 -0.2060 0.1070 -1.9243 0.0552 -0.4166-0.0046 
Outcome: CRC screening adherence 
Variable Coefficient SE z p-value 95% CI 
Constant -10.9344 4.4145 -2.4769 0.0133 -19.5868--2.2821 
Cancer fear 2.1204 1.4631 1.4493 0.1473 -0.7472-4.9880 
Risk-taking -0.0881 0.2767 -0.3183 0.7503 -0.6304-0.4543 
Age 0.1841 0.0718 2.5633 0.0104 0.0433-0.3248 
Interaction (Cancer 
fear x Age) 
-0.0360 0.0239 -1.5074 0.1317 -0.0828-0.0108 
Race1 0.3982 0.2706 1.4716 0.1411 -0.1321-0.9285 
Education level2 0.5097 0.2495 2.0433 0.0410 0.0208-0.9987 
Direct and indirect effects 
 Effect SE z p-value 95% CI 
Direct effect of 
X on Y 
-0.0881 0.2767 -0.3183 0.7503 -0.6304-0.4543 
Conditional indirect effect of X on Y at values of the moderator 
Mediator Age Effect Boot SE 95% CI 
Cancer fear 53 -0.0143 0.0460 -0.1962-0.0343 
Cancer fear 57 -0.0046 0.0267 -0.1065-0.0248 
Cancer fear 62 0.0074 0.0252 -0.0204-0.0998 
Cancer fear 66 0.0171 0.0437 -0.0353-0.1641 
Cancer fear 69 0.0243 0.0605 -0.0509-0.2202 
Index of moderated mediation 
Mediator Index Boot SE Boot 95% CI 
Cancer fear 0.0024 0.0061 -0.0050-0.0232 
Note: N = 327. 
The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes. 
Significant results are displayed in bold. 
Coefficients are unstandardized. 
SE = standard error; CI = confidence interval; CRC = colorectal cancer 
1Race coded as 0 = minority race and 1 = White race. 
2Education level coded as 0 = HS diploma or GED or less and 1 = some college or more. 
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Table 10. Moderated mediation of relationship between self-reliance and colorectal 
cancer screening adherence with race as moderator (Aim #3, Hypothesis #3.2) 
Outcome: Trust in PCP 
Variable Coefficient SE t p-value 95% CI 
Constant 4.7672 0.5636 8.4583 <0.01 3.6584-5.8760 
Self-reliance -0.3143 0.1078 -2.9161 0.0038 -0.5264--0.1023 
Age -0.0040 0.0087 -0.4618 0.6445 -0.0210-0.0130 
Education level1 0.0058 0.1043 0.0555 0.9558 -0.1994-0.2110 
Outcome: CRC screening adherence 
Variable Coefficient SE z p-value 95% CI 
Constant -4.2163 1.7993 -2.3433 0.0191 -7.7430--0.6897 
Trust in PCP -0.0961 0.2811 -0.3418 0.7325 -0.6469-0.4548 
Self-reliance -0.4202 0.2677 -1.5696 0.1165 -0.9450-0.1045 
Race2 0.1388 1.3451 0.1032 0.9178 -2.4976-2.7752 
Interaction (Trust 
in PCP x Race) 
0.0766 0.3189 0.2403 0.8101 -0.5484-0.7017 
Age 0.0831 0.0217 3.8342 0.0001 0.0406-0.1256 
Education level1 0.5072 0.2467 2.0559 0.0398 0.0237-0.9907 
Direct and indirect effects 
 Effect SE z p-value 95% CI 
Direct effect of  
X on Y 
-0.4202 0.2677 -1.5696 0.1165 -0.9450-0.1045 
Conditional indirect effect of X on Y at values of the moderator 
Mediator Race Effect Boot SE 95% CI 
Trust in PCP Black 0.0302 0.1154 -0.1577-0.3146 
Trust in PCP White 0.0061 0.0538 -0.0941-0.1267 
Index of moderated mediation 
Mediator Index Boot SE Boot 95% CI 
Trust in PCP -0.0241 0.1268 -0.3176-0.2058 
Note: N = 327. 
The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes. 
Significant results are displayed in bold. 
Coefficients are unstandardized. 
PCP = primary care provider; SE = standard error; CI = confidence interval; CRC = 
colorectal cancer 
1Education level coded as 0 = HS diploma or GED or less and 1 = some college or more. 
2Race coded as 0 = African American or Black race and 1 = White race
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Table 11. Moderated mediation of relationship between self-reliance and colorectal 
cancer screening adherence with length in patient-provider relationship as moderator 
(Aim #3, Hypothesis #3.3) 
Outcome: Trust in PCP 
Variable Coefficient SE t p-value 95% CI 
Constant 4.7655 0.5644 8.4433 <0.01 3.6551-5.8759 
Self-reliance -0.3104 0.1086 -2.8573 0.0046 -0.5241--0.0967 
Age -0.0036 0.0087 -0.4138 0.6793 -0.0208-0.0136 
Race1 -0.0372 0.1143 -0.3254 0.7451 -0.2620-0.1876 
Education level2 0.0064 0.1045 0.0617 0.9509 -0.1991-0.2120 
Outcome: CRC screening adherence 
Variable Coefficient SE z p-value 95% CI 
Constant -3.9840 1.6426 -2.4254 0.0153 -7.2034--0.7646 
Trust in PCP -0.1131 0.1939 -0.5834 0.5597 -0.4932-0.2670 
Self-reliance -0.3751 0.2657 -1.4119 0.1580 -0.8959-0.1456 
Length of relation. -0.0049 0.0151 -0.3250 0.7452 -0.0345-0.0247 
Interaction (Trust 
in PCP x Length) 
0.0017 0.0034 0.4839 0.6285 -0.0051-0.0084 
Age 0.0787 0.0218 3.6044 0.0003 0.0359-0.1214 
Race1 0.4269 0.2706 1.5776 0.1146 -0.1035-0.9573 
Education level2 0.4943 0.2473 1.9985 0.0457 0.0095-0.9791 
Direct and indirect effects 
 Effect SE z p-value 95% CI 
Direct effect of 
X on Y 
-0.3751 0.2657 -1.4119 0.1580 -0.8959-0.1456 
Conditional indirect effect of X on Y at values of the moderator 
Mediator Length  Effect Boot SE 95% CI 
Trust in PCP 0 0.0351 0.0723 -0.0830-0.2189 
Trust in PCP 10.51 0.0297 0.0627 -0.0735-0.1891 
Trust in PCP 31.18 0.0190 0.0500 -0.0704-0.1381 
Trust in PCP 78.92 -0.0057 0.0693 -0.1529-0.1366 
Trust in PCP 118.14 -0.0260 0.1122 -0.2823-0.1883 
Index of moderated mediation 
Mediator Index Boot SE Boot 95% CI 
Trust in PCP -0.0005 0.0013 -0.0036-0.0018 
Note: N = 327 
The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes. 
Significant results are displayed in bold. 
Coefficients are unstandardized. 
PCP = primary care provider; SE = standard error; CI = confidence interval; Length = 
length of patient-provider relationship; CRC = colorectal cancer 
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Table 11, continued. 
1Race coded as 0 = African American or Black race and 1 = White race. 
2Education level coded as 0 = HS diploma or GED or less and 1 = some college or more. 
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Table 12. Logistic regression analyses predicting colorectal cancer screening adherence 
as a function of masculinity norms (Aim 4) 
 
Variables B SE 
Wald chi-
square (df=1) 
Odds 
ratio 
95% CI for 
odds ratio 
Block 
1 
Race1 
Age 
Education level2 
Physician 
recommend.3 
Family/friend 
recommend.4 
Constant 
-0.329 
0.085** 
-0.413 
-2.640** 
 
-0.403 
 
-3.919** 
 .286 
 .023 
 .263 
 .570 
 
 .260 
 
1.426 
 1.327 
13.633 
 2.470 
21.416 
 
 2.393 
 
 7.553 
0.719 
1.088 
0.662 
0.071 
 
0.668 
 
0.020 
0.411-1.260 
1.041-1.139 
0.396-1.107 
0.023-0.218 
 
0.401-1.113 
Block 
2 
Race1 
Age 
Education level2 
Physician 
recommend.3 
Family/friend 
recommend.4 
Heterosexual self-
present. 
Self-reliance 
Risk-taking 
Constant 
-0.411 
0.084** 
-0.436     
-2.677** 
 
-0.417 
 
0.258      
 
-0.411 
0.176      
-3.938* 
 .294 
 .023 
 .269 
 .574 
 
 .262 
 
 .207 
 
 .280 
 .300 
1.574 
 1.946 
13.034 
 2.620 
21.712 
 
 2.524 
 
 1.548 
 
 2.154 
 0.344 
 6.262 
0.663 
1.087 
0.647 
0.069 
 
0.659 
 
1.294 
 
0.663 
1.192 
0.019 
0.372-1.181 
1.039-1.138 
0.382-1.096 
0.022-0.212 
 
0.394-1.102 
 
0.862-1.943 
 
0.383-1.148 
0.663-2.144 
Note: N = 327; *p < .05. **p < .01.  
The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes.   
Significant results are displayed in bold. 
Beta coefficients are unstandardized. 
Table 12, continued. 
SE = standard error; CI = confidence interval; CRC = colorectal cancer 
1Race coded as 0 = minority race and 1 = White race. 
2Education level coded as 0 = HS diploma or GED or less and 1 = some college or more. 
3Physician recommendation coded as 0 = no and 1 = yes. 
4Family/friend recommendation coded as 0 = no and 1 = yes. 
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Table 14. Logistic regression analysis predicting endoscopic CRC screening as a function 
of masculinity norms (modified Aim 5) 
 
Variables B SE 
Wald chi-
square 
(df=1) 
Odds 
ratio 
95% CI for 
odds ratio 
Block 
1 
Age 
Race1 
Education level2 
Constant 
0.086** 
-0.306 
-0.550* 
-4.469** 
0.022 
0.270 
0.251 
1.371 
15.159 
 1.291 
 4.819 
10.623 
1.090 
0.736 
0.577 
0.011 
1.044-1.139 
0.434-1.249 
0.353-0.943 
Block 
2 
Age 
Race1 
Education level2 
Heterosexual self-
presentation 
Self-reliance 
Risk-taking 
Constant 
0.086** 
-0.402 
-0.580* 
0.162 
 
-0.476 
-0.005 
-4.069** 
0.022 
0.279 
0.257 
0.199 
 
0.275 
0.284 
1.506 
14.540 
 2.071 
 5.103 
 0.668 
 
 2.987 
 0.000 
 7.300 
1.089 
0.669 
0.560 
1.176 
 
0.621 
0.995 
0.017 
1.042-1.138 
0.387-1.156 
0.339-0.926 
0.797-1.736 
 
0.362-1.066 
0.570-1.737 
Note: N = 310. *p < .05. **p < .01.  
Endoscopic CRC screening coded as 0 = no and 1 = yes. 
Significant results are displayed in bold. 
Coefficients are unstandardized. 
SE = standard error; CI = confidence interval; CRC = colorectal cancer 
1Race coded as 0 = minority race and 1 = White race. 
2Education level coded as 0 = HS diploma or GED or less and 1 = some college or more. 
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Figure 1. Study flowchart 
Veterans approached in clinic 
n = 561 
Recruitment 
Refused prior to eligibility 
screening 
n = 151 
- Not interested: 139
- Study participation too much work: 9
- Too sick/Health reasons: 8
- Unable to complete paperwork/Possible 
literacy issues: 5 
- Prior bad CRC screening experience of
self/other: 5 
- Concerns about privacy: 3
- Did not want to specify/No reason: 3
- In another study/Consider participation in 
another study: 3 
- Wouldn’t benefit individual himself: 2
- Dislikes surveys: 2
- No time: 2
- Other: 6
Veterans screened for eligibility 
n = 410 
Eligibility 
Refused following screening 
n = 5 
- Not interested: 4
- Concerns about privacy: 2
Veterans found to be 
ineligible 
n = 55 
- Adherent to CRC screening guidelines prior 
to change in eligibilty criteria: 15 
- Cognitive issues: 14
- Literacy issues: 8
- FDR with diagnosis of early CRC: 6
- 2 or more FDRs with CRC: 6
- Personal history of CRC: 5
- Personal history of ulcerative 
colitis/FAP/Lynch Syndrome: 3
Veterans eligible and consented 
n = 350 
Data collection 
Veterans with data utilized in 
current study 
n = 327 
Data analysis 
Veterans with incomplete data 
n = 23 
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Figure 1, continued.  
 
Note: CRC = colorectal cancer; FDR = first degree relative; FAP = familial adenomatous 
polyposis 
 
Change in eligibility criteria during the course of the study: Originally, according to 
eligibility criteria, only 150 individuals from each group (i.e., adherent and non-adherent 
to CRC screening) were to be consented. However, due to low numbers of non-adherent 
veterans, eligibility criteria were altered such that this criterion was omitted.  
 
Veterans could indicate more than one reason for refusal and, thus, reason for refusal 
totals do not equal the number of the individuals who refused to participate.     
 
  
129 
 
Figure 2. Heterosexual self-presentation model 
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes. 
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Figure 3. Risk-taking model 
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes. 
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Figure 4. Self-reliance model 
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes. 
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Figure 5. Risk-taking mediation model 
 
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes. 
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Figure 6. Self-reliance mediation model  
 
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes. 
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Figure 7. Risk-taking moderated mediation model 
 
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes. 
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Figure 8. Self-reliance moderated mediation model #1 
 
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes. Race coded as 0 = 
minority race and 1 = White race.  Significant results are displayed in bold. 
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Figure 9. Self-reliance moderated mediation model #2 
 
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes.  PCP = primary 
care provider.  Significant results are displayed in bold. 
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Appendix A: Health Questions 
 
1. Has a doctor ever told you that you had colon or rectal cancer?  
Yes           No 
2. Have any of your close blood relatives ever had colon or rectal cancer?  By close 
blood relatives, I mean your parents, brothers, sisters, or children. 
Yes           No 
 
3. If “yes” to question #2, how many of your close blood relatives (parents, sisters, 
brothers, or children) have had cancer of the colon or rectum? 
___________ 
 
4. If “yes” to question #2, did any of these relatives have cancer of the colon or 
rectum before they were 60 years old?  
 
Yes           No 
 
5. Have you ever been told you have ulcerative colitis or Crohn's disease?  
        
Yes           No 
 
6. Have you ever been told you have Lynch syndrome or familial adenomatous 
polyposis?   
 
Yes           No 
 
7. Has a doctor ever told you that you had colon or rectal polyps that were not 
cancer?  
 
Yes      No 
 
 
Now there are some questions about colorectal cancer testing.
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The stool blood test, which is sometimes called a Hemoccult or fecal occult blood test or 
fecal immunochemical test, is something you do at home to examine your stool for 
hidden blood.  The test requires you to place a small sample of your stool or bowel 
movement on a special card that comes in a kit.  This card is then sent to your doctor’s 
office or to a lab for testing.  
 
8. Have you done a stool blood test at home and mailed or brought the cards back to 
your doctor’s office or a lab in the past 12 months?    
         Yes           No 
 
During a sigmoidoscopy, a doctor inserts a thin, flexible tube with a light into your 
rectum to examine your colon for any unusual growths.  The tube is shorter than the one 
used for a colonoscopy and does not allow the doctor to see as much of your colon.  You 
rarely need medicine to help you relax for this test.  The test usually takes about 15 
minutes.  
 
9. Have you had a sigmoidoscopy in the past 5 years?   
Yes           No 
 
A colonoscopy is a test where a doctor inserts a thin, flexible tube with a light into your 
rectum to examine your colon for any unusual growths.  Right before the test, you get 
some medicine to help you relax.  The test usually takes 30 to 60 minutes, depending on 
whether there are growths or polyps that need to be removed.  Afterward, you wait for 
the relaxing medicine to wear off, and someone has to drive you home.   
 
10. Have you had a colonoscopy in the past 10 years?   
Yes           No 
 
 
 
 
 
 
THANK YOU FOR YOUR PARTICIPATION!
  
139 
Appendix B:  Health Experiences 
 
1. Have you ever been diagnosed with a cancer other than colon, rectal, or skin 
cancers?  
                                                                                                            Yes           No 
 
2. Have any of your friends or co-workers had colon or rectal cancer?  
Yes           No 
 
3. Have any of your distant blood relatives had colon or rectal cancer? This would 
include your grandparents, aunts, uncles, or cousins. 
Yes           No 
 
4. Have any family members or friends encouraged you to have a colon test?        
Yes           No 
 
Now there are some questions about the stool blood test, which is sometimes called a 
Hemoccult or fecal occult blood test or fecal immunochemical test.  This is 
something you do at home to examine your stool for hidden blood.  The test requires 
you to place a small sample of your stool or bowel movement on a special card that 
comes in a kit.  This card is then sent to your doctor’s office or to a lab for testing. 
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5. Has a doctor ever recommended that you do a stool blood test?                      
        Yes           No   
 
6. Have you ever done a stool blood test at home and mailed or brought the cards back 
to your doctor’s office or a lab?                  Yes           No 
 
7. If yes to question #6, when did you do your most recent stool blood test at home?  
Month: ____________________ Year: ________________ 
 
8. If yes to question #6, did you send your most recent stool blood test to the VA? 
Yes           No 
 
During a sigmoidoscopy, a doctor inserts a thin, flexible tube with a light into your 
rectum to examine your colon for any unusual growths.  The tube is shorter than the one 
used for a colonoscopy and does not allow the doctor to see as much of your colon.  You 
rarely need medicine to help you relax for this test.  The test usually takes about 15 
minutes. 
 
9. Has a doctor ever recommended you have a sigmoidoscopy?   Yes           No     
 
10. Have you ever had a sigmoidoscopy?      Yes           No 
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11. If yes to question #10, when was your most recent sigmoidoscopy?  
Month: ____________________ Year: ________________ 
 
12. If yes to question #10, was your most recent sigmoidoscopy completed at the VA?   
 
Yes           No 
 
A colonoscopy is a test where a doctor inserts a thin, flexible tube with a light into your 
rectum to examine your colon for any unusual growths.  Right before the test, you get 
some medicine to help you relax.  The test usually takes 30 to 60 minutes, depending on 
whether there are growths or polyps that need to be removed.  Afterward, you wait for 
the relaxing medicine to wear off, and someone has to drive you home.   
 
13. Has a doctor ever recommended you have a colonoscopy?   Yes           No     
 
14. Have you ever had a colonoscopy?      Yes           No 
 
15. If yes to question #14, when was your most recent colonoscopy?  
Month: ____________________ Year: ________________ 
 
16. If yes to question #14, was your most recent colonoscopy completed at the VA?   
 
Yes           No 
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Note: The instructions for the Trust in Physician measure and all 5 items of the 
Trust in Physician measure were located here in the study questionnaire. 
 
Note: The instructions for the Conformity to Masculine Norms meaure and all 46 
items of the Conformity to Masculine Norms Inventory were located here in the 
study questionnaire.  
 
Note: The instructions for the Cancer Fear measure and all 8 items of the Cancer 
Fear measure were located here in the study questionnaire. 
 
General Information 
 
1. Age:   ___________ years 
 
2. What race or ethnicity do you consider yourself to be?        ___White   
___Black or African American   ___Asian-American or Pacific Islander 
___Native American             ___Hispanic or Latino  ___Other (please 
specify)__________________________ 
 
3. Marital Status (check one)   ___Single ___Living with partner     
___Married       ___Separated        ___Divorced        ___Widowed 
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4. Employment status (check one)   ___Employed full-time               
___Employed part-time     ___Student     ___Homemaker        ___Retired        
            ___Unemployed, looking for work     ___Unemployed, due to disability 
             ___Other (please specify) ______________________________ 
 
5. What is the highest grade or year of school you completed?     
___Never attended school or only attended kindergarten  
___Grades 1 through 8 (Elementary)  
___Grades 9 through 11 (Some high school)  
___Grade 12 or GED (High school graduate)  
___College 1 year to 3 years (Some college or technical school)  
___ College 4 years or more (College graduate)  
___Graduate school (Master’s degree, Doctorate, etc.) 
 
6. Do you have health insurance coverage now (outside of VA benefits)?  
         Yes           No 
 
7. What is your combined yearly household income before taxes?                    
___ $0-$10,999 ___$11,000-$20,999  ___$21,000-$30,999 
___$31,000-$50,999 ___$51,000 to $99,999 ___$100,000 or more 
 
 
THANK YOU FOR YOUR PARTICIPATION! 
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PROFESSIONAL INTERESTS 
______________________________________________________________________ 
Research Interests: 
 Cancer Preventive Health Beliefs and Behaviors  
 Health Disparities  
 Medical Decision-making  
 Health Literacy 
 Cancer Care across the Continuum 
 
Clinical Interests: 
 Health Psychology and Behavioral Medicine  
 Adaptation to Physical Illness such as Cancer 
 Psychosocial Contributors to Health and Illness Management 
 Preventive Health Beliefs and Behaviors  
 Health Disparities 
 Stress and Coping 
______________________________________________________________________ 
GRANTS AND FELLOWSHIPS 
______________________________________________________________________ 
2013 Scott Mesh Honorary Grant for Research in Psychology, July 2013, American 
Psychological Association of Graduate Students  
 
Clinical Psychology Program Research Grant, May 2013, IUPUI Department of 
Psychology  
 
Clinical Psychology Program Travel Grant, April 2013, IUPUI Department of 
Psychology  
 
Educational Enhancement Grant, February 2013, IUPUI Graduate and Professional 
Student Government  
 
Indiana University Simon Cancer Center Cancer Prevention and Control Pilot Funding, 
March 2012-March 2014, Barriers and Facilitators of Colonoscopy Completion after 
Referral. Susan M. Rawl, PhD, RN, FAAN (PI). Role: Co-Investigator  
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National Cancer Institute R25 award. Training in Research for Behavioral Oncology and 
Cancer Control. R25-CA117865, July 2011-June 2014. Victoria L. Champion, PhD, 
RN, FAAN (PI). Role: Predoctoral Fellow. Primary mentor: Susan M. Rawl, PhD, RN, 
FAAN; Secondary mentor: Catherine E. Mosher, PhD  
 
Educational Enhancement Grant, April 2011, IUPUI Graduate and Professional Student 
Government  
 
Clinical Psychology Program Travel Grant, April 2011, IUPUI Department of 
Psychology  
______________________________________________________________________ 
HONORS AND AWARDS 
______________________________________________________________________ 
Elite 50 Award, April 2015, IUPUI Graduate and Professional Student Government 
 
Research Excellence Award, April 2014, IUPUI Department of Psychology, Clinical 
Psychology Program  
 
Second Place Behavioral Science by a Graduate Student Poster Award, May 2013, 
Indiana University Simon Cancer Center Annual Cancer Research Day 2013 
 
Clinical Psychology Award (for outstanding clinical work), March 2013, IUPUI 
Department of Psychology, Clinical Psychology Program  
 
Honorable Mention for the Clinical Psychology Award for Citizenship, March 2013, 
IUPUI Department of Psychology, Clinical Psychology Program 
 
First Place Behavioral Science by a Graduate Student Poster Award, May 2012, Indiana 
University Simon Cancer Center Annual Cancer Research Day 2012 
 
First Place Poster Award in Outcome Oriented Research, April 2012, Richard L. 
Roudebush VAMC 4th Annual Scientific Symposium 2012 
 
Graduate School Dean’s Citation for Academic Excellence, July 2010, Ball State 
University 
 
Departmental Honors in Psychology, May 2003, Miami University 
 
President’s List, January 2003-May 2003, Miami University  
 
Eshbaugh Botany Scholarship, 2003, Miami University 
 
Parents’ Council Certificate of Merit for Community Service,  2003, Miami University 
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Phi Beta Kappa, National Academic Honor Society, April 2003, Miami University 
chapter 
 
Psi Chi Honor Society, March 2002, Miami University chapter 
 
Golden Key International Honor Society, October 2002, Miami University chapter 
 
Dean’s List, January 2001-December 2002, Miami University 
 
Dean’s List, September 1999-December 2000, Wright State University 
______________________________________________________________________ 
PEER-REVIEWED PUBLICATIONS 
______________________________________________________________________    
1. Rawl, S.M., Christy, S.M., Monahan, P., Tong, Y., Krier, C., Champion, V.L., & Rex, 
D. (in press). Tailored telephone counseling increases colorectal cancer screening. 
Health Education Research. Manuscript in press. 
2. Winger, J.G., Christy, S.M., & Mosher, C.E. (2015). Associations of health behaviors 
with Human Papillomavirus vaccine receipt and intentions among female college 
students. Journal of Health Psychology. doi: 10.1177/1359105315569093 
3. Christy, S.M., Mosher, C.E., & Rawl, S.M. (2014). Integrating men’s health and 
masculinity theories to explain colorectal cancer screening behavior. American Journal 
of Men’s Health, 8, 54-65. doi: 10.1177/1557988313492171  
4. Wang, H.L., Christy, S.M., Skinner, C.S., Champion, V.L., Springston, J.K., Perkins, 
S.M., Tong, Y., Krier, C., Gebregziabher, N., & Rawl, S.M. (2014). Predictors of stage 
of adoption for colorectal cancer screening among African American primary care 
patients. Cancer Nursing, 37, 241-251. doi: 10.1097/NCC.0b013e3182a40d8d 
5. Christy, S.M., & Rawl, S.M. (2013). Shared decision-making about colorectal cancer 
screening: A conceptual framework to guide research. Patient Education and 
Counseling, 91, 310-317. doi: 10.1016/j.pec.2013.01.015 
6. Christy, S.M., Perkins, S.M., Tong, Y., Krier, C., Champion, V.L., Skinner, C.S., 
Springston, J.K., Imperiale, T.F. & Rawl, S.M. (2013). Promoting colorectal cancer 
screening discussion: A randomized controlled trial. American Journal of Preventive 
Medicine, 44, 325-329. doi:10.1016/j.amepre.2012.11.032 
7. Christy, S.M., Mosher, C.E., Sloane, R., Snyder, D.C., Lobach, D., & Demark-
Wahnefried, W. (2011). Long-term dietary outcomes of the FRESH START intervention 
for breast and prostate cancer survivors. Journal of the American Dietetic Association, 
111, 1844-1851. doi: 10.1016/j.jada.2011.09.013 
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______________________________________________________________________ 
MANUSCRIPTS UNDER REVISION 
______________________________________________________________________          
Rawl, S.M., Perkins, S., Tong, Y., Christy, S.M., Krier, C., Wang, H.L., Russell, K., 
Huang, A.M., Rhyant, B., Lloyd, F., Willis, D., Imperiale, T., Myers, L.J., Champion, V 
L., Springston, J., & Skinner, C.S. (2015). Computer-delivered tailored intervention 
increases colorectal cancer screening in low-income African Americans in primary care. 
Manuscript under revision.   
 
Brittain, K., Christy, S.M., & Rawl, S.M. (2015). Cultural variables related to colorectal 
cancer screening: Trust, health temporal orientation, health literacy, fatalism, and 
knowledge. Manuscript under revision. 
______________________________________________________________________ 
MANUSCRIPTS IN PREPARATION 
______________________________________________________________________        
Christy, S.M., Winger, J.G., Persons, E., Halpern, L., Danoff-Burg, S., & Mosher, C.E. 
(2015). Anticipated regret, health beliefs, and HPV vaccination intentions in young 
adults. Manuscript in preparation. 
 
Christy, S.M., Smith-Howell, E., & Rawl, S.M. (2015). Correlates of cancer fatalism in 
the context of colorectal cancer screening. Manuscript in preparation.   
______________________________________________________________________ 
PRESENTATIONS 
______________________________________________________________________ 
National Presentations: 
 
1. Christy, S.M., Brittain, K., & Rawl, S.M. (2014, April). African American patients’ 
intent to screen for colorectal cancer: Do cultural factors, health literacy, knowledge, 
age and gender matter? Poster presented at the 2014 Annual Meeting of the Society of 
Behavioral Medicine, Philadelphia, PA. 
 
2. Winger, J.G., Christy, S.M., & Mosher, C.E. (2014, April). Health behaviors 
associated with HPV vaccine receipt and intentions among undergraduate women. 
Poster presented at the 2014 Annual Meeting of the Society of Behavioral Medicine, 
Philadelphia, PA. 
 
3. Rawl, S., Olofinkua, K., Habermann, B., Christy, S., Perkins, S., Tong, Y., 
Gebregziabher, N., Mabis M., Krier, C., Mirchandani, A. & Fatima, H. (2014, April). 
Colorectal cancer knowledge differentiates people who complete a scheduled 
colonoscopy and those who do not. Poster presented at the 2014 Annual Meeting of the 
Society of Behavioral Medicine, Philadelphia, PA. 
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4. Olofinkua, K., Rawl, S.M.,  Habermann, B., Christy, S., Perkins, S., Tong, Y.,  
Gebregziabher, N., Krier, C., Mirchandani, A., Mabis, M., & Fatima, H. (2014, April). 
Primary care patients who complete colonoscopy after referral and those who do not: 
Are they different? Poster presented at the 2014 Annual Conference of the National 
Council of Undergraduate Research, Lexington, KY.   
 
5. Christy, S.M., Persons, E., Halpern, L., Danoff-Burg, S., & Mosher, C.E. (2013, July). 
Health beliefs, attitudes, and HPV vaccination intention in college men. Poster presented 
at the 2013 American Psychological Association Annual Convention, Honolulu, HI.   
 
6. Christy, S., Wang, H., Perkins, S., Tong, Y., Champion, V., Skinner, C., & Rawl, S. 
(2013, March). Mediators of change in stage of adoption following two colorectal 
screening interventions. Poster presented at the 2013 American Society of Preventive 
Oncology Annual Meeting, Memphis, TN. 
 
7. Rawl, S.M., Perkins, S., Tong, Y., Christy, S., Champion, V.L., & Skinner, C.S. 
(2012, November). Computer-tailored intervention increases colon cancer screening in 
low-income Black primary care patients: Results of a randomized trial. Paper presented 
at the 2012 Oncology Nursing Society Research Conference, Phoenix, AZ. 
 
8. Christy, S.M., Perkins, S., Tong, Y., Gebregziabher, N., Krier, C., Champion, V.L., 
Skinner, C.S., Springston, J., Rhyant, B., Imperiale, T., & Rawl, S.M. (2012, 
September). Predictors of colorectal cancer screening discussions between Black 
primary care patients and their providers. Paper presented at the 2012 National State of 
the Science Congress on Nursing Research, Washington, D.C.  
 
9. Rawl, S.M., Perkins, S., Tong, Y., Krier, C., Christy, S., Wang, H-L., Champion, 
V.L., Springston, J., & Skinner, C.S. (2012, September). Increasing colorectal cancer 
screening in low-income Black primary care patients: 6 month results of a randomized 
trial. Poster presented at the 2012 National State of the Science Congress on Nursing 
Research, Washington, D.C. 
 
10. Wang, H-L., Skinner, C.S., Champion, V.L., Springston, J., Perkins, S., Tong, Y., 
Krier, C., Gebregziabher, N., Christy, S., & Rawl, S.M. (2012, September). Factors 
predicting stage of adoption for fecal occult blood testing and colonoscopy among non-
adherent African Americans. Paper presented at the 2012 National State of the Science 
Congress on Nursing Research, Washington, D.C. 
 
11. Christy, S.M., Mosher, C.E., Lipkus, I., Sloane, R., Snyder, D.C., Lobach, D.F., & 
Demark-Wahnefried, W. (2012, June). Long-term outcomes of the FRESH START trial: 
Exploring the role of self-efficacy in cancer survivors’ maintenance of dietary practices 
and physical activity. Poster presented at the 2012 Biennial Cancer Survivorship 
Conference, Arlington, VA. 
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12. Wang, H-L., Skinner, C.S., Champion, V.L., Springston, J., Perkins, S., Tong, Y., 
Krier, C., Gebregziabher, N., Christy, S., & Rawl, S.M. (2012, May). Colorectal cancer 
screening in non-adherent Black Americans. Poster presented at the 2012 Cancer, 
Culture & Literacy Conference, Clearwater Beach, FL. 
 
13. Christy, S.M., Perkins, S., Tong, Y., Gebregziabher, N., Krier, C., Champion, V., 
Skinner, C.S., Springston, J., Rhyant, B., Imperiale, T., & Rawl, S. (2012, April). 
Predictors of colorectal cancer screening discussions between African-American 
patients and their providers. Poster presented at the 2012 Annual Meeting of the Society 
of Behavioral Medicine, New Orleans, LA. 
 
14. Christy, S.M., Mosher, C.E., Sloane, R., Snyder, D.C., Lobach, D., & Demark-
Wahnefried, W. (2011, April). Long-term dietary outcomes of the FRESH START 
intervention for breast and prostate cancer survivors. Poster presented at the 2011 
Annual Meeting of the Society of Behavioral Medicine, Washington, D.C. 
 
Local Presentations: 
 
15. Christy, S.M., Brittain, K., & Rawl, S.M. (2014, May). African American patients’ 
intent to screen for colorectal cancer: Do cultural factors, health literacy, knowledge, 
age and gender matter? Poster presented at the 2014 Indiana University Simon Cancer 
Center Cancer Research Day, Indianapolis, IN. 
 
16. Winger, J.G., Christy, S.M., & Mosher, C.E. (2014, May). Health behaviors 
associated with HPV vaccine receipt and intentions among undergraduate women. 
Poster presented at the 2014 Indiana University Simon Cancer Center Cancer Research 
Day, Indianapolis, IN. 
 
17. Van Antwerp, L.R., Christy, S.M., Mosher, C.E., Rawl, S.M., & Haggstrom, D.A. 
(2014, April). Predictors of colorectal cancer screening adherence among male 
veterans. Poster presented at the 2014 IUPUI Research Day, Indianapolis, IN. 
 
18. Christy, S.M., Wang, H., Perkins, S.M., Tong, Y., Champion, V.L., Krier, C., Myers, 
L.J., Imperiale, T., Skinner, C.S., & Rawl, S.M. (2013, May). Change in stage of 
adoption following two colorectal cancer screening interventions. Poster presented at the 
2013 Indiana University Simon Cancer Center Cancer Research Day, Indianapolis, IN. 
 
19. Christy, S.M., Wang, H., Perkins, S.M., Tong, Y., Champion, V.L., Krier, C., Myers, 
L.J., Imperiale, T., Skinner, C.S., & Rawl, S.M. (2013, May). Change in stage of 
adoption following two colorectal cancer screening interventions. Poster presented at the 
2013 Richard L. Roudebush VAMC 4th Annual Scientific Symposium, Indianapolis, IN 
(presented by C. Krier). 
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20. Rawl, S.M., Christy, S., Perkins, S., Tong, Y., Krier, C., Wang, H-L., Champion, V. 
L., Myers, L.J., Imperiale, T., Willis, D., Rhyant, B., Springston, J., & Skinner, C.S. 
(2013, April). Interventions to promote colorectal cancer screening in primary care: 
Results of a randomized trial. Poster presented at the 2013 IUPUI Research Day, 
Indianapolis, IN. 
 
21. Van Antwerp, L.R., Winger, J.G., Christy, S.M., & Mosher, C.E. (2013, April). 
Relationships between health behaviors and HPV vaccine receipt and intentions among 
undergraduate women. Poster presented at the 2013 IUPUI Research Day, Indianapolis, 
IN. 
 
22. Christy, S.M., Perkins, S., Tong, Y., Gebregziabher, N., Krier, C., Champion, V., 
Skinner, C.S., Springston, J., Rhyant, B., Imperiale, T., & Rawl, S. (2012, May). 
Predictors of colorectal cancer screening discussions between African-American 
patients and their providers. Poster presented at the 2012 Indiana University Simon 
Cancer Center Cancer Research Day, Indianapolis, IN. 
 
23. Christy, S.M., Perkins, S., Tong, Y., Gebregziabher, N., Krier, C., Champion, V., 
Skinner, C.S., Springston, J., Rhyant, B., Imperiale, T., & Rawl, S. (2012, April). 
Predictors of colorectal cancer screening discussions between African-American 
patients and their providers. Poster presented at the 2012 Richard L. Roudebush VAMC 
4th Annual Scientific Symposium, Indianapolis, IN.  
______________________________________________________________________ 
RESEARCH EXPERIENCE 
______________________________________________________________________ 
Co-investigator and Research Team Member, October 2011-July 2015 
Colonoscopy Scheduled and Subsequent Test (COAST) Research Team 
School of Nursing 
Indiana University, Indianapolis, Indiana 
 
Duties:         Co-designed mixed methods study; co-wrote Abstract, Specific  
                      Aims, and Approach sections of successful grant application for pilot  
                            study funding; attend research team meetings; perform qualitative  
                            data coding. 
 
Supervisor:          Susan M. Rawl, PhD, RN, FAAN 
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Research Team Member, July 2011-July 2015 
Promoting African American Colon Testing (PACT) Research Team 
School of Nursing 
Indiana University, Indianapolis, Indiana 
 
Duties:        Conduct data analyses and prepare manuscripts; attend research  
                        team meetings. 
 
Supervisor:     Susan M. Rawl, PhD, RN, FAAN 
 
Graduate Research Assistant, August 2010-June 2014 
Department of Psychology 
Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 
 
Duties:              Recruited participants and conducted assessments for NCI-funded  
                          research on the support needs and preferences of lung cancer patients  
                         and their caregivers; co-designed studies on HPV vaccination  
                          acceptance and other health behaviors; conducted literature searches  
                          and compiled measures; conducted data analyses and prepared  
                          manuscripts; trained, mentored, and supervised undergraduate research 
assistants; collected information from medical records; maintained 
study databases and participant files; assisted with intervention design 
and grant preparation; provided training in clinical skills and medical 
chart data extraction to research assistants and trial therapists. 
 
Supervisor:         Catherine E. Mosher, PhD 
 
Data Manager, August 2009-January 2010 
Department of Counseling Psychology 
Ball State University, Muncie, Indiana 
 
Duties:                 Assisted with data entry and organization for a doctoral student’s  
                            dissertation entitled, The moderating and mediating effects of     
                           religious coping on quality of life in long-term survivors of cancer. 
 
Supervisor:         Sarah Jenkins, MA, Doctoral Candidate  
                            Donald Nicholas, PhD, HSPP 
 
 
 
 
 
 
 
 
  
153 
Student Researcher, August 2007-July 2010 
Health Psychology Research Team  
Department of Counseling Psychology 
Ball State University, Muncie, Indiana 
 
Duties:             Assisted other student researchers through survey preparation and  
                         data entry; discussed research methods; assisted in data collection   
                        for meta-analysis. 
 
Supervisor:      Donald Nicholas, PhD, HSPP 
 
Undergraduate Research Assistant, August 2002-May 2003  
Department of Psychology 
Miami University, Oxford, Ohio 
 
Duties:           Mentored independent study experience in APA-style manuscript  
   writing.     
                              
Supervisor:       Z. Michael Nagy, PhD 
 
______________________________________________________________________ 
CLINICAL EXPERIENCE 
______________________________________________________________________ 
Clinical Health Psychology Intern, July 2014-June 2015 
VA Connecticut Healthcare System-West Haven campus 
West Haven, Connecticut 
 
Integrated Primary Care Clinic (August 2014-June 2015): 
Duties:                  Conduct time-limited, evidence-based individual psychotherapy  
                             (e.g., Cognitive-Behavioral Therapy, Motivational Interviewing) and  
                             assessments with veterans presenting with a wide range of co- 
                             morbid physical and psychological diagnoses in order to improve  
                             health behaviors and medical self-management strategies and to  
                             facilitate coping with medical diagnoses as well as prevention of  
                             chronic illnesses. Work within a multidisciplinary team of medical  
                             care providers. Serve in a consultation role to other medical care  
                             providers to improve patient care.   
 
Supervisors: Jessica Barber, PhD, Laura Blakley, PhD, Caroline Schmidt, PhD and John 
Sellinger, PhD 
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Cancer Center (January 2015- June 2015):  
Duties:                  Conduct assessments and provide individual and group therapy to  
                              individuals facing a hematology or oncology diagnosis. Conduct  
                              evaluations for bone marrow transplantation.  
 
Supervisor: Jessica Barber, PhD 
 
Integrated Pain Clinic (August 2014-December 2014): 
Duties:                  Conduct cognitive-behavioral assessments with veterans with pain  
                             conditions in order to determine the biological, psychological, and  
                             social contributors to their pain experience. Work within a  
                             multidisciplinary team which includes psychology, pain medicine,  
                             physiatry, physical therapy, pharmacy, and substance abuse  
                             treatment professionals in order to provide a comprehensive pain  
                             evaluation and develop a pain management plan and  
                             recommendations.  
 
Supervisor: John Sellinger, PhD 
Preceptor: Laura Wandner, PhD 
 
Inpatient Consultation-Liaison Service (July 2014- June 2015): 
Duties:                   Conduct assessments and provide psychotherapy to individuals who  
                              are currently inpatient in a variety of medical and surgical units  
                              within the medical center. Serve as a consultant and make  
                              recommendations to medical staff surrounding patients’  
                              psychosocial functioning and coping.     
 
Supervisors: Jessica Barber, PhD, Laura Blakley, PhD, Caroline Schmidt, PhD, and John 
Sellinger, PhD 
Preceptor: Kristina Schumann, PhD  
 
Clinical Health Psychology Assessment Clinic (August 2014- June 2015): 
Duties:                   Conduct evaluation and participate in treatment planning for  
                               individuals diagnosed with a variety of co-morbid physical and  
                               psychological diagnoses. Write reports following clinical interview  
                               and psychological evaluation for organ transplantation. 
 
Supervisor: Jessica Barber, PhD 
Preceptors: Aaron Martin, PhD and Noel Quinn, PhD 
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Smoking Cessation Clinic (August 2014-November 2014): 
Duties:                  Co-facilitate smoking cessation group by providing psychoeducation  
                              around smoking cessation strategies through Cognitive-Behavioral    
                              and Motivational Interviewing techniques.  
 
Supervisor: Lisa Frantsve, PhD 
Preceptor: Anthony Brinn, PsyD 
 
Weight Management Clinic (July 2014-October 2014 and March 2015- June 2015): 
Duties:                 Co-facilitate the Managing Overweight/Obese Veterans Everywhere  
                            (MOVE!) weight management groups with colleagues from the  
                            physical therapy and nutrition services. Provide psychoeducation  
                            surrounding behavioral and cognitive weight management strategies. 
 
Supervisor: Lindsey Dorflinger, PhD 
Preceptor: Leila Islam, PhD 
 
Interdisciplinary Stroke Clinic (November 2014-February 2015): 
Duties:                 Conduct assessments with individuals who have suffered a stroke or  
                             other cerebrovascular injury in order to identify risk factors for  
                             subsequent brain injuries. Work within an interdisciplinary team of  
                             neurology, pharmacy, physical therapy, and psychology in order to  
                             make recommendations for behavioral change to reduce secondary  
                             stroke risk.  
 
Supervisor: Valerie Weisser, PhD                               
                              
Palliative Care (March 2015- June 2015):  
Duties:                  Provide supportive therapy and conduct assessments with  
                              individuals who are receiving inpatient palliative care services in a  
                              variety of medical and surgical units. Serve as a consultant and  
                              make recommendations to medical staff surrounding patients’  
                              psychosocial functioning and coping. 
 
Supervisor: Laura Blakely, PhD 
                              
Audiology Clinic (March 2015- June 2015): 
Duties:                  Co-facilitate Cognitive-Behavioral Therapy-based tinnitus  
                              management group and conduct cochlear implant evaluations.  
 
Supervisor: Caroline Schmidt, PhD                      
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Practicum Student, January 2013-April 2013 
Richard L. Roudebush VA Medical Center 
Indianapolis, Indiana 
Duties:                 Conducted neuropsychological and personality assessments with  
                             veterans with a variety of referral questions including traumatic  
                             brain injuries, compensation and pension evaluations, dementia, and  
                             severe mental illness. Wrote integrated reports based upon clinical  
                             interview and assessment results.  
 
Supervisor:          Kriscinda Whitney, PhD, HSPP 
 
Peer Supervisor, September 2012-May 2013 
Indiana University-Purdue University Indianapolis, Department of Psychology 
Indianapolis, Indiana 
 
Duties: Provided peer supervision to Clinical Psychology PhD students who 
were earlier in their practica careers.  
 
Supervisor:          John Guare, PhD, HSPP 
 
Practicum Student, August 2012-December 2012 
Larue D. Carter Memorial Hospital 
Indianapolis, Indiana 
 
Duties: Provided group and individual therapy (Cognitive-Behavioral Therapy,  
                            Dialectical Behavioral Therapy, Behavioral Therapy) to adult patients  
                            in an inpatient setting. Co-led Borderline Personality Disorder and  
                            Transition Skills groups. Conducted assessments with individuals  
                            diagnosed with severe mental illnesses. 
 
Supervisor:          Kristine M. Chapleau, PhD, HSPP 
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Practicum Student, August 2011-April 2012 
Richard L. Roudebush VA Medical Center 
Indianapolis, Indiana 
 
Duties:           Provided individual and group therapy (Cognitive-Behavioral  
 Therapy, Cognitive Processing Therapy, Acceptance and  
 Commitment Therapy, Motivational Interviewing) to adult clients in 
 an integrated primary care setting. Led Chronic Pain Management 
 and Managing Overweight/Obese Veterans Everywhere (MOVE!) 
 Level 2 weight management groups. Conducted mood, personality,   
 intelligence, and neuropsychological assessments. Wrote integrated  
 reports following clinical interview and psychological evaluation for  
 Interferon treatment and Spinal Cord Stimulator implants. 
 
Supervisor:          Jennifer Lydon-Lam, PhD, HSPP 
 
Practicum Student, April 2011-August 2011 
Adult Outpatient Clinic, Department of Psychiatry, Indiana University School of 
Medicine, University Hospital 
Indiana University Simon Cancer Center 
Indianapolis, Indiana 
 
Duties:  Provided individual therapy (Cognitive-Behavioral Therapy,  
 Acceptance and Commitment Therapy) to cancer patients and family  
 caregivers at Indiana University Simon Cancer Center. Provided  
 individual therapy (Cognitive-Behavioral Therapy, Acceptance and  
 Commitment Therapy) to adult clients at Adult Outpatient Clinic. 
 
Supervisor:          Natalie Dattilo, PhD, HSPP 
 
Interim Program Director, May 2010-June 2010 
Cancer Support Community, formerly The Wellness Community of Central Indiana 
Indianapolis, Indiana 
 
Duties: Led bi-weekly Facilitator Supervision meetings for LCSW and  
 LFMT staff; created, designed, and planned program calendar and  
 secured speakers for programs; served as point person for individuals 
 interested in programming; maintained program statistics and  
    completed various administrative tasks; created upcoming program  
    marketing materials; trained incoming Program Director; co-organized  
    Survivors Symposium 2010 and served as moderator of Survivor Panel  
    at Survivors Symposium 2010. 
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Clinical Program Intern, August 2009-May 2010 
Cancer Support Community, formerly The Wellness Community of Central Indiana 
Indianapolis, Indiana 
 
Duties:  Conducted cancer patient and caregiver support groups and intake  
 interviews; engaged in public outreach and programming;  
 maintained program statistics; provided individual counseling;  
 fulfilled Program Director tasks while Program Director was on  
 maternity leave from September through December 2009. 
                           
Supervisors: Alan Maugherman, PhD, HSPP 
                         Janet Wilson, MSW, LCSW 
                        Laura Weiger, MSW, LCSW 
 
Counselor in training, May 2009-July 2009 
Ball State University Counseling Practicum Clinic 
Muncie, Indiana 
 
Duties:           Provided individual and family counseling (Interpersonal Therapy,  
                       Cognitive-Behavioral Therapy) to the public.  
 
Supervisors:      Donald Nicholas, PhD, HSPP 
                       Kristen Jones, MA 
 
Counselor in training, May 2009-July 2009 
Ball State University Wellness Group 
Muncie, Indiana 
 
Duties:           Co-led psycho-educational group for older adults on health-related  
           and psychosocial topics in residential setting. 
 
Supervisors:      Donald Nicholas, PhD, HSPP 
                     Summer Ibarra, MA 
               Aarika Vannatter, MA 
 
Counselor in training, January 2009-May 2009 
Wilson Middle School 
Muncie, Indiana 
 
Duties:     Provided individual, family, and group counseling to students and  
             their parents (Interpersonal Therapy, Cognitive-Behavioral Therapy). 
                          
Supervisors:      Alan Maugherman, PhD, HSPP 
                Jennifer Walsh, MA 
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Rape Victim Advocate, October 2002-April 2013 
Butler County Crisis & Counseling Center 
Oxford, Ohio   
 
Duties:        Provided emotional support and information to rape victims via phone 
and face-to-face contact as volunteer advocate. 
 
Supervisor:      Jennifer Weigel, MSW, LISW 
______________________________________________________________________ 
MENTORING AND TEACHING EXPERIENCE 
______________________________________________________________________ 
Presentation and co-facilitation of Cognitive Behavioral Therapy Skills Training for 
Yale University School of Medicine Primary Care Residents, March 2015, St. Raphael’s 
Hospital, New Haven, Connecticut 
 
Presented “Personality” guest lecture to undergraduate Introduction to Psychology class, 
October 2014, University of New Haven, West Haven, Connecticut 
 
Assisted with design and facilitation of Cognitive Behavioral Therapy Skills Training for 
Yale University School of Medicine Primary Care Residents, October 2014, St. 
Raphael’s Hospital, New Haven, Connecticut 
 
Presented “Anxiety Disorders” guest lecture to undergraduate Abnormal Psychology 
class, September 2014, University of New Haven, West Haven, Connecticut 
 
Mentored undergraduate Psychology student throughout Honor’s thesis project and 
Capstone course, July 2013-May 2014, IUPUI, Indianapolis, Indiana 
 
Mentored undergraduate Psychology student’s successful Undergraduate Research 
Opportunities Program Project grant application entitled “Predictors of Colorectal 
Cancer Screening Adherence among Male Veterans” awarded by the IUPUI Center for 
Research and Learning, August 2013-December 2013, IUPUI, Indianapolis, Indiana 
 
Completed the “Seminar in Teaching Psychology” course, May 2012-July 2012, IUPUI, 
Indianapolis, Indiana 
______________________________________________________________________ 
PROFESSIONAL MEMBERSHIPS 
______________________________________________________________________ 
American Society of Preventive Oncology, January 2013-Present, Student member 
 
American Psychological Association Division 51: Society for the Psychological Study of 
Men and Masculinity, January 2013-December 2014, Student member 
 
American Psychological Association Division 12: Clinical Psychology, May 2012- 
December 2013, Student member 
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Society of Behavioral Medicine, September 2010-Present, Student member 
 
American Psychological Association Division 38: Health Psychology, 2010, 2012-
Present, Student member 
 
Ball State University Social Justice League, May 2009-July 2010 
 
American Psychological Association, September 2007-Present, Student member 
(APAGS member) 
 
Psychology Club, September 2002-May 2003, Miami University 
______________________________________________________________________ 
EDITORIAL ACTIVITIES                                                                                                                                             
______________________________________________________________________         
Mentored Ad Hoc Manuscript Reviews: 
          Psycho-Oncology (x2) 
          Social Science Research  
          Journal of Consulting and Clinical Psychology  
______________________________________________________________________ 
WORKSHOPS ATTENDED 
______________________________________________________________________ 
Motivational Interviewing for PACT Clinicians, September 2014 
Presenters: Lindsey Dorflinger, PhD, Clinical Psychologist, Health Behavior  
                   Coordinator, VA Connecticut Healthcare System, Department of  
                   Psychiatry, Yale University School of Medicine 
                   Jacquelyn Wolf MSN, RN, CDE, Health Promotion, Disease Prevention  
                   Coordinator, VA Connecticut Healthcare System  
Location: VA Connecticut Healthcare System, Newington, Connecticut 
 
Biofeedback for Pain Management, April 2014 
Presenter: Eric Scott, PhD, HSPP, Assistant Professor of Clinical Psychology in   
                 Clinical Psychiatry, Indiana University 
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 
 
Mixed Methods in the Social, Behavioral, Health Sciences and STEM Fields, February 
2014 
Presenter: John W. Creswell, PhD, Professor of Educational Psychology, University  
                  of Nebraska-Lincoln; Visiting Professor, School of Public Health, Harvard  
                  University 
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 
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Consultation Workshop, October 2013 
Presenter: Susan Hickman, PhD, Associate Professor, Indiana University School of  
                 Nursing 
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 
 
Scientific Writing from the Reader’s Perspective, July 2013 
Presenter: George Gopen, JD, PhD, Professor, Duke University 
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 
 
Self-Hypnosis for Chronic Pain Management, April 2013 
Presenter: Mark Jensen, PhD, Professor, University of Washington 
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 
 
Consultation Workshop: Focus on Fidelity and Feedback, January 2013 
Presenter: Angela Rollins, PhD, Roudebush Veterans Affairs Medical Center 
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 
 
Write Winning Grant Proposals, October 2012 
Presenter: John Robertson, PhD, Grant Writers’ Seminars & Workshops 
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 
 
Overview of Mental Health and Behavioral Consultation, October 2011 
Presenter: Lisa Ruble, PhD, Associate Professor of Educational Psychology, 
                 University of Kentucky 
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 
 
Group Schema Therapy Workshop, March 2011 
Presenters: Joan Farrell, PhD, Adjunct Professor, Indiana University School of  
                  Medicine, Department of Psychiatry and Training Director of the Center for     
                  Borderline Personality Disorder Treatment & Research; Ida Shaw, M.A.,           
                  Director of BASE Consulting Group 
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 
______________________________________________________________________ 
WORK EXPERIENCE 
______________________________________________________________________ 
Museum Administrator, January 2004-January 2009 
Indiana Landmarks, formerly Historic Landmarks Foundation of Indiana 
Indianapolis, Indiana 
 
Duties:       Gave invited podium presentations at Association of American  
                            Museums conference in 2005 and Association of Indiana Museums  
                            conference in 2006; performed budget planning and maintenance  
                            duties; completed grant writing and fund-raising duties; performed  
                            public speaking tasks including television interviews; executed all  
                            duties described below in Program Manager position.  
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Program Manager, July 2003-December 2003 
Indiana Landmarks, formerly Historic Landmarks Foundation of Indiana 
Indianapolis, Indiana 
 
Duties:              Engaged in exhibit and program research, planning, and production;  
                          performed public speaking tasks through guided tours, education and  
                         special event program presentation, and radio programming; 
 mentored undergraduate and graduate Public History and Museum 
 Studies student interns; engaged in frequent contact with the public, 
 volunteers, interns, advisory committee members, and board 
 members. 
______________________________________________________________________ 
SERVICE ACTIVITIES 
______________________________________________________________________ 
University Service: 
Campus Representative for American Psychological Association, Society of Clinical 
Psychology (Division 12), May 2012-December 2013 
Indiana University-Purdue University Indianapolis  
Indianapolis, Indiana 
 
Campus Representative for American Psychological Association of Graduate Students 
Advocacy Coordinating Team (ACT), September 2010-September 2011 
Indiana University-Purdue University Indianapolis  
Indianapolis, Indiana 
 
Social Justice League Website Committee Member, February 2010-July 2010 
Ball State University 
Muncie, Indiana 
 
Graduate Studies Committee member, September 2009-July 2010 
Department of Counseling Psychology 
Ball State University 
Muncie, Indiana 
 
Community Service: 
American Cancer Society, 2011 
2011 Relay for Life Team Co-Captain 
Indianapolis, Indiana 
 
Board of Directors Member, October 2007-January 2009 
Secretary of the Board 
Chair of the Nominating Committee 
Association of Indiana Museums 
Indianapolis, Indiana 
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Board of Directors Member, May 2007-July 2008 
Old Centrum Foundation 
Indianapolis, Indiana 
